- Research
- Open access
- Published:
Impeding microbial biofilm formation and Pseudomonas aeruginosa virulence genes using biologically synthesized silver Carthamus nanoparticles
Microbial Cell Factories volume 23, Article number: 240 (2024)
Abstract
Long-term antibiotic treatment results in the increasing resistance of bacteria to antimicrobials drugs, so it is necessary to search for effective alternatives to prevent and treat pathogens that cause diseases. This study is aimed for biological synthesis of silver Carthamus nanoparticles (Ag-Carth-NPs) to combat microbial biofilm formation and Pseudomonas aeruginosa virulence genes. Ag-Carth-NPs are synthesized using Carthamus tenuis aqueous extract as environmentally friendly method has no harmful effect on environment. General factorial design is used to optimize Ag-Carth-NPs synthesis using three variables in three levels are Carthamus extract concentration, silver nitrate concentration and gamma radiation doses. Analysis of response data indicates gamma radiation has a significant effect on Ag-Carth-NPs production. Ag-Carth-NPs have sharp peak at λ max 425 nm, small and spherical particles with size 20.0 ± 1.22 nm, high stability up to 240 day with zeta potential around − 43 ± 0.12 mV, face centered cubic crystalline structure and FT-IR spectroscopy shows peak around 620 cm−1 that corresponding to AgNPs that stabilized by C. tenuis extract functional moiety. The antibacterial activity of Ag-Carth-NPs against pathogenic bacteria and fungi was determined using well diffusion method. The MIC values of Ag-Carth-NPs were (6.25, 6.25, 3.126, 25, 12.5, 12.5, 25 and 12.5 µg/ml), MBC values were (12.5, 12.5, 6.25, 50, 25, 25, 50 and 25 µg/ml) and biofilm inhibition% were (62.12, 68.25, 90.12, 69.51, 70.61, 71.12, 75.51 and 77.71%) against Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Bacillus subtilis, Staphylococcus aureus, Staphylococcus epidermidis, Candida tropicalis and Candida albicans respectively. Ag-Carth-NPs has bactericidal efficacy and significantly reduced the swarming, swimming motility, pyocyanin and protease production of P. aeruginosa. Furthermore, P. aeruginosa ToxA gene expression was significantly down regulated by 81.5%, while exoU reduced by 78.1%, where lasR gene expression reduction was 68%, while the reduction in exoU was 66% and 60.1% decrease in lasB gene expression after treatment with Ag-Carth-NPs. This activity is attributed to effect of Ag-Carth-NPs on cell membrane integrity, down regulation of virulence gene expression, and induction of general and oxidative stress in P. aeruginosa. Ag-Carth-NPs have no significant cytotoxic effects on normal human cell (Hfb4) but have IC50 at 5.6µg/mL against of HepG-2 cells. Limitations of the study include studies with low risks of silver nanoparticles for in vitro antimicrobial effects and its toxicity.
Introduction
Nanotechnology has emerged as one of the most promising technologies to overcome the crisis of drug resistance microbes [1,2,3,4]. Chemical vapor deposition, microwave, laser ablation, ultrasonic radiation, and electrochemical methods are a few frequently used for metallic nanoparticles synthesis, because these methods are characterized by high production costs and the use of hazardous and toxic compounds, which may have detrimental impacts on human health and the environment [5]. Green synthesis in which mostly uses plant extracts, is an environmentally acceptable method to produce metallic nanoparticles without having to deal with hazardous chemicals, because compounds derived from plant extracts (flavonoids, polyphenols, proteins, sugars, and saponins) act as stabilizing and reducing agents metals instead hazardous chemicals [6].The biological synthesis of nanoparticles using plants and plant extracts appears to be an attractive alternative to conventional chemical synthesis [7,8,9]. Recently, synthesizing metal nanoparticles using plants has been extensively studied and has been recognized as a green and efficient method [10, 11]. The biological synthesis of metal nanoparticles has low toxicity when compared with other methods [12]. They are used natural extracts for example, as tomato, paprika, or marigold extracts, fenugreek, lupin, and other plants for biological synthesis of metals nanoparticles [13,14,15]. Use of Gymnanthemum amygdalinum extracts for Se-NPs biosynthesis [16]. Synthesis of copper nanoparticles Using Krameria sp. Root extract [17]. Leaf extracts of Clerodendrum Inerme were used for the generation of silver nanoparticles [18].
There are about 47 species in the genus Carthamus (family Asteraceae), 15 of which are found in Western Asia and the Middle East region, Carthamus tenuis is one of them [19]. While several of these species were explored for their potential medical uses, it’s odd that not much research was done on C. tenuis, despite the fact that it’s widely distributed throughout the Middle East [20]. C. tenuisleaves and stems aqueous extract it has not been used before in the formation of nanoparticles and is neglected in use in the Middle East. Most previous researches are focused on Carthamus tinctorius no Carthamus tenuis. Additionally, they show that the plant is traditionally used in Egypt as an aphrodisiac, to promote fertility, to prevent abortions and as antimicrobial herbal medicine[21]. The crop holds significant industrial value as a result of its ability to extract commercial oil. Moreover, the substances found in its petals serve as natural food coloring [22]. Nevertheless, after the seed is extracted, over 80% of this product (leaf or stem) is regarded as an agricultural waste [23]. Flavonoids, quinochalcones, polyacetylenes, alkaloids, fatty acids, steroids, lignans, proteins, and polysaccharides are among the chemical families that have been identified from safflower; quinochalcones and flavonoids are the primary active chemicals [24, 25], that play important role in reduction and stabilization of nanoparticles. Plant extracts have been shown to possess antibacterial properties due to the presence of phenolic chemicals [3, 26]. Safflower’s antibacterial activity is probably caused by polyphenols rupturing membranes and allowing biological components to escape. Thus, substances that disrupt membranes cause cellular contents to leak out and obstruct metabolic enzymes, which inactivates bacteria[27].
Recently, as an alternative to antibiotics, the use of different nanoparticles (NPs) to treat bacterial infections [28, 29] and fungal infection has been increasing in popularity [30]. A significant advancement in nanotechnology is the use of silver nanoparticles compared to other metals, because of their great stability, low chemical reactivity and have special physicochemical features, they have drawn a lot of interest in biological applications [31]. The high surface area and distinct chemical and physical properties of silver nanoparticles have made them effective antimicrobial agents against multidrug resistant microbes [9]. Silver nanoparticles remarkable antibacterial properties make it an essential tool for tissue regeneration, cancer treatment, wound healing, and infection prevention[32]. Furthermore, AgNPs exhibit significant potential as adaptable drug carriers for targeted treatments and as contrast agents for cutting-edge medical imaging methods [33]. Silver nanoparticles can kill organisms by causing breakdown of the cytoplasmic membrane and cell wall, then liberating silver ions (Ag +) to adhere to or go through the membrane, causing ribosome denaturation and stopping protein production [34].According to their earlier research, biofilm formation in Escherichia coli, Pseudomonas aeruginosa, and Klebsiella pneumoniae was inhibited within 24 h by increasing the concentration of silver nanoparticles from 12.5 to 100 μg/ml [35]. Silver Nano that applied to textile materials for wound dressing can prevent bacterial adhesion and biofilm formation [36].
Bacterial biofilms are bacterial communities embedded in a selfproduced polymeric matrix (extracellular polymeric substance) that adheres to surfaces and their interface, this biofilm shields the bacterium from antimicrobial agents and host immune responses [37].Biofilm forming organisms have a natural resistance to antibiotics, disinfectants, and germicides [38, 39]. The biofilm bacteria can withstand higher antibiotic concentrations than bacteria in suspension makes it more difficult to eradicate a persistent illness linked to biofilm formation [40]. The production of several virulence factors further aids pathogenicity and infection by biofilm-forming bacterial pathogens [41]. The bacterial infections that produce biofilms are responsible for causing mutant cells to become more resistant to antibiotics [42]. It is now widely known that biofilms are extremely difficult to remove and frequently resistant to systemic antibiotic therapy [43]. P. aeruginosa is a gram negative bacterium widely distributed in the environment, usually inhabiting soil, water, plants, and humans [44]. P. aeruginosa infects individuals suffering from immunodeficiency, cystic fibrosis, burn wounds, cancer, chronic obstructive pulmonary disease (COPD), and severe infections that need to be ventilated, such COVID-19 [45]. In all biological domains, P. aeruginosa is also a widely used model bacteria[46]. P. aeruginosa virulence factors that are related to disease development in healthy organisms and resistance to antibiotics [47]. The use of nanoparticles to inhibit P. aeruginosa virulence factors is a promising strategy [48]. Biologically synthesized silver nanoparticles are reported as anti-QS and antibiofilm drugs against P. aeruginosa infections[49]. Previous study show a significantly decreased the expression of quorum sensing regulatory genes of P. aeruginosa; lasR, lasI, pqsA, fliC, exoS and pslA with Ag-MET-NEs [50]. Ag-nanoparticles can inhibit virulence factors of microbes, this action mechanism is related to their effect on the integrity of cell membranes, the down regulation of the expression of virulence genes, and the creation of oxidative and general stress in microorganisms[51]. Novelty of the study is Ag-Carth-NPs using C. tenuis aqueous extract, where C. tenuis it has not been used before in the formation of nanoparticles and is neglected in use in the Middle East.
The current study aimed to biological synthesis of silver Carthamus nanoparticles (Ag-Carth-NPs) to combat pathogenic microbe’s biofilm formation and P. aeruginosa virulence genes.
Materials and methods
Chemicals
The ingredients of the media utilized in the microbiological examination were obtained from Oxoid, and silver nitrate, Clindamycin, Nystatin, Crystal Violet, ethanol was obtained from Sigma-Aldrich.
Preparation of safflower (Carthamus tenuis) aqueous extract
Plant sample
Fresh samples of Carthamus tenuis were collected locally from Abu El Matamir, Al Buhayrah, Egypt, 2023. The C. tenuis waste used in the present investigation consisted of a mixture of stem and leaf obtained after the seed collection process. The sample was collected 150 days after sowing. The plant samples leafs and stems were cleaned using sterile distilled water and then dried at room temperature (25 ℃ for 1 weeks), after drying the leaf and stem samples was ground into powder using a blender. The dried plant materials were stored in a dark area until needed.
Extraction of bioactive compounds
Extraction of Carthamus tenuis was performed according to the modified method described by [52]. Briefly, 5.0 g of fine safflower powder was immersed in 100 ml of sterile distilled water for 3 h on magnetic stirrer at 80 ℃. Finally, it was centrifuging the macerate at 4000 rpm and 5 ℃ using a cooling centrifuge, the supernatants were was recovered and filtered on Whatman #4 paper, and then dried at room temperature (25 ℃) and stored at 5 ℃ until used for nanoparticles synthesis.
Preparation of Silver- Carthamus nanoparticles
Optimization of silver- Carthamus nanoparticles (Ag-Carth-NPs) synthesis
A general factorial design was used to compare the influence of different parameters on the synthesis of silver nanoparticles [15]. The statistical software package used was Design-Expert 7.0 (Stat Ease Inc., Minneapolis, U.S.A) to determine the factors that have positive and significant effects on the process. Certain factors were chosen as they have the most meaningful impact on AgNPs synthesis. The influences of the three variables in three levels are Carthamus extract (1, 2, and 3 × 102 µg/ml disolved in DMSO), silver nitrate concentration (0.5, 1and 1.5 × 102 µg/ml disolved in sterile deionized water), and gamma radiation doses (0, 1, and 5 kGy). All samples was mixed by v/v using magnetic stirrer at 25 ℃. and then exposed to gamma radiation according to Table 1. Responses as optical density (OD) was meaured after radiation using UV-visible spectroscopy at wavlentgh 425 nm to estimated how the main parameter affects the synthesis of Ag-Carth-NPs after 24 h of reaction time.
Validation of Ag-Carth-NPs and stability
The size and morphology of the synthesized Ag-Carth-NPs were characterized using the following techniques. Transmission electron microscope (TEM) (TEM-JEOL electron microscope JEM-100 CX) operating at 80 kV accelerating energy is great for characterizing the size and shape of nanoparticles [53]. Particle size, particle size distribution and Zeta potential was determined by Dynamic light scattering (DLS) Zetasizer Technique (PSS-NICOMP 380-ZLS, USA) where 250 μl of suspension transferred to a disposable small volume cuvette. While the Fourier transforms infrared spectroscopy (FT-IR) was employed to assess the function moiety [54], where the samples were recorded in KBr pellets using an FT-IR (JASCO FT-IR -3600). Using X-ray diffraction analysis, the crystalline structure of the produced metallic nanoparticles [55], was established. Cu-Ka target and nickel filter were used in the study of extended X-ray diffraction models (Shimadzu apparatus -Shimadzu Scientific Instruments; SSI, Japan). Operating at 50.0 mA and 40.0 kV, with a flow rate of 2/min, and a 2 h value between 20 and 100, a Cu anode is used. The intensity of the diffracted X-rays is determined based on the diffracted angle 2 h.
The stability of Ag-Carth-NPs was estimated at different storage time ranged from 1 to 240 day at room temperature (25 ℃ and neutral pH (7.0) using by UV-vis spectroscopy [56, 57]. Further, the zeta potential was measured to assess the stability and solubility of Ag-Carth-NPs in aqueous solution.
Antimicrobial assays
Microorganism
Microbial strains: In this study standard strain were kindly provided from culture collection of Drug Microbiology Lab, Drug Radiation Research Department, Biotechnology Division, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority. In addition to clinical isolates of P. aeruginosa were used and selected after screening of more than 50 P. aeruginosa clinical isolate. The selection of P. aeruginosa clinical isolates based on higher resistant to free silver nitrate and Carthamus extract solution. Preparation and sterilizing the agar plates was done according to previous described study [58], with slightly significant modification (Supplementary data).
A colony of the required strain was picked from the stock plates and transferred to 10mL of LB medium to prepare the overnight bacterial cultures (37 ℃, 200 rpm, using an orbital shaker incubator). The overnight cultures were refreshed by adding fresh LB medium and incubated at 37 ℃ for approximately 1 h. We aimed to reach the appropriate OD 600 corresponding to the known concentration of bacteria expressed as CFU per ml. Each bacterial culture was diluted in sterile 0.9% NaCl to an initial concentration of about 1 × 106 cells per mL.
Inhibition zone diameter
The antimicrobial activity of Ag-Carth-NPs was determined by using the agar diffusion method [59, 60] against gram positive bacteria Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATTC 12228 and Bacillus subtilis ATCC 6633 and gram negative bacteria like Escherichia coli RCMB 0020B01, Klebsiella pneumoniae ATTC 13883, P. aeruginosa clinical isolate; additionally, antifungal towards Candida tropicalis RCMB001Y004 and Candida albicans ATCC 10231.
The agar plate surface is inoculated by spreading a volume of the microbial inoculum (1 × 106 cells per ml) over the entire agar surface. Then, a well (with a diameter of 6 mm) is made aseptically using a sterile corkborer. The well was diffused with 50 µl of each tested sample: Ag-Carth-NPs at 100 µg/ml. Carthamus extract (2 × 102 µg/ml) and silver nitrate (1 × 102 µg/ml) was used as negative control and Clindamycin 2 μg/ml and Nystatin 100 μg/ml as positive control, then incubated at 37 ℃ for 24 h [61, 62]. The measurement of inhibition was carried out by observing the emergence of a clear zone.
Minimum inhibitory concentration (MIC) determination and minimum bactericidal concentration (MBC)
The MIC was determined by well diffusion method based on the guidelines of the Clinical Laboratory Standard Institute (CLSI) [63]. The MIC of Ag-Carth-NPs was identified to determine the lowest concentration that inhibits the visible growth of the test organisms. Different concentrations of Ag-Carth-NPs (100, 50, 25, 12.5, 6.25, 3.125, and 1.625 µg/ml) were used. The procedure was repeated three times and the mean value was taken into consideration. In these experiments, a positive control (nutrient plus microorganism), and negative control one (the nutrient only) had been used. The data within the samples are analyzed using one way analysis of variance (ANOVA).
After the MIC determination of the Ag-Carth-NPs, aliquots of 10 µl samples from all the tubes which showed no visible bacterial growth were seeded on Brain Heart Infusion Agar (BHI agar) plates and incubated for 24 h at 37 ℃. When 99.9% of the bacterial population is killed at the lowest concentration of an antimicrobial agent, it is termed as the minimum bactericidal concentration (MBC) endpoint [64]. This was done by observing pre and post-incubated agar plates for the presence or absence of bacterial colonies. The procedure was repeated three times and the mean value was taken into consideration. The data within the samples are analyzed using one way analysis of variance (ANOVA).
Anti-biofilm activity
The biofilm qualitative and quantitative formation analysis was performed in the absence and presence of Ag-Carth-NPs against all tested organisms. A semi-qualitative detection of biofilm formation was determined according to Elbasuney, [65]. Fifty microliters of the chosen microbes overnight culture in LB, the broth turbidity was adjusted at 0.5McFarland Standards (5 × 105 CFU/ml). The microbial suspension was put to the tubes contain two milliliters of sterilized LB broth, and these tubes were kept at 37 ℃ for 1 day after addition of Ag-Carth-NPs at sub-MIC (0.25MIC, 0.5MIC and 0.75MIC) to each separate tubes. The experiment also included tubes containing media alone represented negative controls and tube contain media plus tested organisms in absence of Ag-Carth-NPs represented as positive control. Following incubation, the broth culture was poured out and washed with three PBS (PBS; pH 7.0). Next, the bacterial and yeast cells biofilms that adhered to the tube walls were fixed using sodium acetate (3.5%) for approximately 20 min. For thirty minutes, the insides of the tubes were stained with 10 mL 0.1% crystal violet dye. While the excess dye was decanted and washed off with deionized water gently, the tubes were dried and the biofilm formation ability was determined by observing a thin layer of blue film on the walls of tubes.
The microtiter plate technique was utilized for quantitative estimation of biofilm formation [66]. Using 96-well microtiter plates, the assay involved inoculating each well with 100 μl of LB broth, 10 μl of culture cultured overnight and diluted further to a final concentration of 5 × 105 CFU/ml, and 10 μl of Ag-Carth-NPs at sub-MIC (0.25MIC, 0.5MIC and 0.75MIC) was measured against the chosen microbes. After being incubated at 37 ℃ for 24 h, the contents of the wells was carefully removed and three times cleaned with PBS (PBS; pH 7.0) to get rid of any bacteria. After that, biofilms were fixed with sodium acetate sodium acetate (3.5%) and stained for ten minutes with 50 μl of 0.1% crystal violet dye. After being dyed and affixed to wells, the cells were dried and cleaned with distilled water. 200 μl of 95% ethanol was added in each well to elute the attached cells, and absorbance was measured at 600 nm on ELISA reader in order to quantify cells capable of forming biofilms. Negative and positive controls were also used in the assay.
The inhibition percentage was calculated using equation (1)
Time-Kill curve assay
Time-kill assay was done in MHB medium as described by Loo et al. [9]. The inoculums were adjusted to 106 CFU/millimeter. The Ag-Carth-NPs solution was diluted with MHB media containing microbial inoculums to obtain the final concentration of 0 MIC, 0.5 MIC, 1 MIC, 2MIC and 4MIC, for each type of microbes in the total final volume of 1 ml. The cultures were then incubated at 37 ℃ with 140 rpm agitation. The cultures (100 µl) were spread on MHA plates at time 0, 1, 2, 4 and 8 h. The experiment was carried out in triplicate. The number of colonies on the MHA plates was quantified in CFU/mL after incubation at 37 ℃ for 24 h and then, their growth rate was identified through reading OD600 using fixed UV- spectroscopy.
Statistical Analysis- One way ANOVA: The results represent the mean±SD from at least three independent experiments. One-way ANOVA with Tuckey post-hox test, using Graph 10 software (*P<0.05; **P<0.01 and ***P<0.001) was performed (*P<0.05; **P<0.01 and ***P<0.001) compare to the control group.
Motility of P. aeruginosa assay
Swarming motility assay In order to test the capacity of the Ag-Carth-NPs to block the swarming motility of P. aeruginosa clinical isolate was performed as discussed earlier [67]. A clinical isolate of P. aeruginosa was grown in Luria Bertani broth (LB) for 24 h then bacterial suspension was adjusted to reach an OD600=1. The swarming medium composed of LB along with 0.5% (w/v) casamino acids and 0.4% (w/v) Bacto agar. Before agar solidification, 0.5MIC concentration of Ag-Carth-NPs was added, and then 2.5 µl fresh bacterial culture was placed on the surface of the medium, followed by incubation at 35 ℃ for 24 h. and bacterial swarming zone was then measured [68]. All motility experiments were performed in triplicate. All motility experiments were performed in triplicate. Tubes contain media plus P. aeruginosa in absence of Ag-Carth-NPs represented as positive control.
Swimming assay Ag-Carth-NPs were tested for their impact on P. aeruginosa using a plate-based swimming assay. To put it briefly, the petri dishes were filled with Luria broth medium that included 0.3% agar and 0.5MICs Ag-Carth-NPs. Next, bacterial cells were added to the plate’s agar layer using sterile yellow pipette tips (not to the base of the Petri plate). After a 24-hour incubation period, the swimming phenotype's radial growth was measured on the plates [69]. Tubes contain media plus P. aeruginosa in absence of Ag-Carth-NPs represented as positive control.
Pyocyanin level
In order to determine how Ag-Carth-NPs affected P. aeruginosas capability to produce pyocyanin, bacterial cultures in an LB medium containing 0.5MIC Ag-Carth-NPs were created in tubes. The tubes were shaken at 80 rpm for 48 h at 37 ℃. Following centrifugation of the cultures, samples of the cell-free supernatant (CFS) were taken. After that, 4 ml of the CFS samples were mixed with 2 ml of chloroform, vortexed, and centrifuged for 15 mins. Then, the chloroform layer was transferred to a fresh tube and mixed with 1 ml of 0.2 M HCl. After centrifugation again, the top layer was removed and OD at 520 nm was measured [70]. Tubes contain media plus P. aeruginosa in absence of Ag-Carth-NPs represented as positive control.
Total proteases inhibition assay
Using the modified skimmed milk broth method, the effect of Ag-Carth-NPs on inhibition of total proteases by P. aeruginosa isolates was investigated. To acquire the supernatants, P. aeruginosa overnight cultures in MHB with and without 0.5MIC of the Ag-Carth-NPs were centrifuged. 500 μl aliquots of bacterial supernatants were cultured for 1 h at 37°C with 1 ml of 1.25 percent skim milk. Using a Biotek spectrofuorometer (USA), the drop in optical density of skimmed milk was measured at 600 nm and was thought to be estimate for proteolytic activity [50]. Tubes contain media plus P. aeruginosa in absence of Ag-Carth-NPs represented as positive control.
Gene expression
Effect of Ag-Carth-NPs on relative genes expression P. aeruginosa clinical isolate were tested for virulence genes using real-time reverse transcriptase-polymerase chain reaction (rt-PCR) according to the following steps
Bacterial DNA extraction DNA extraction from samples was performed using the QIAamp DNA Mini kit (Qiagen, Germany, GmbH) as previously described [71] with modifications from the manufacturer’s recommendations. Oligonucleotide Primer; Primers used were supplied from Metabion (Germany) are listed with specific references [72,73,74,75] in Table 1s. PCR reaction and Analysis of the PCR Products were performed in an applied biosystem 2720 thermal cycler as published before [76].
Bacterial RNA extraction and quantitative real-time PCR (qRT-PCR)
Total RNA was isolated from clinical isolate stain of P. aeruginosa cells cultured in the presence or absence of Ag-Carth-NPs (0.5MIC) in order to analyze the expression genes. The RNeasy Mini kit (Qiagen, Germany, GmbH) and the TRIzol reagent (Invitrogen, Waltham, MA, USA) were used for the extraction process. To eradicate DNA contamination, the RQ1-DNAse kit (Promega, USA) was utilized. The A260/A280 ratio calculation and agarose gel electrophoresis were used to confirm the quality of the extracted RNA. Primer-BLAST and BioEdit Sequence Alignment Editor were used to generate and analyze primers after gene sequences were taken from Gen Bank. The primers pair’s sequences for individual genes are presented with references [72, 75] in Table 2s. The QuantiNova SYBR Green RT-PCR kit (QIAGEN, Germantown, MA, EUA) was used to perform RT-qPCR in a final volume of 20 µl. The kit contained 10 µl of SYBR Green RT-PCR Master Mix, 0.2 µl of RT mix, 1 µl (20 µM) of each primer, 5 µl of bacterial RNA (50 ng/µl), and 2.8 µl of RNase-free water. Using the Rotor-Gene Q 2plex (QIAGEN, Germantown, MA, EUA) for the reaction, the following procedures were followed: 10 min of reverse transcription at 50 ℃, 2 min of initial denaturation at 95 ℃, 40 cycles of 95 ℃ for 5 s, and 10 s of hybridization and extension at 60 ℃. The changes in the expression level of target gene were analyzed by using the method adopted by Livak and Schmittgen [77].
Evaluation of cytotoxic effects
The cytotoxic action of Ag-Carth-NPs on the Hfb4 cells (normal skin cell lines) and HepG-2 cells (human Hepatocellular carcinoma) was determined as previously described by [54, 78];. A volume of 100 µl/well of Ag-Carth-NPs at concentrations 100, 50, 25, 12.5, 6.25, 3.125 and 1.56 µg/ml was injected into the 96-well microliter plate containing 1 × 106 HepG-2 cells or and Vero cells. The samples were incubated for 4 h at 37 ℃, 5% CO2. Controls are wells were left without Ag-Carth-NPs. The absorbance at λ=570 nm was measured using a plate reader. The relation between surviving cells and Ag-Carth-NPs concentration is plotted to get the survival curve of each tumor cell line after treatment with the specified compound The Cytotoxic concentration (CC50), the concentration required to cause toxic effects in 50% of intact cells, was estimated from graphic plots of the dose response curve for each conc. using Graphpad Prism software (San Diego, CA. USA).
Statistical analysis
The results represent the mean±SD from at least three independent experiments. One-way ANOVA with Tuckey post-hox test, using Graph 10 software (*P<0.05; **P<0.01 and ***P<0.001) was performed (*P<0.05; **P<0.01 and ***P<0.001) compare to the control group.
Results and discussion
Optimization of silver- Carthamus nanoparticles synthesis
The experimental factorial design was used in this study for screening factors that significantly effect on the final Ag-Carth-NPs production. Responses optical density (O.D) estimated how the main parameter effects on the Ag-Carth-NPs production (Table 1) where, OD values is was triplicate measured at fixed wavelength 425 nm using UV-visible spectroscopy. All parameters, such as concentration of Carthamus extract (1, 2, and 3 × 102 µg/ml), silver nitrate concentration (0.5, 1 and 1.5 × 102 µg/ml), and gamma radiation doses (0, 1, and 5kGy) were maintained constantly.
The results showed that, trial no (7) has high peak optical intensity (O.D a.u) about 4.42 ± 0.21 in competing with other trials that show optical density at range from 1.02±0.038 to 3.12±0.031 (Table 1); where high value of OD indicates higher yields of NPs [79]. The variation in the OD value coincides with nanoparticles production amount [80], trial with high OD indicate high yield of NPs than trial with low OD [81]. Factorial design indicates that, the maximum yield of Ag-Carth-NPs (OD = 4.42) was achieved with run corresponds to an actual 1 × 102 µg/ml Ag-nitrate, 5kGy and 2 × 102 µg/ml Carthamus dry extract. Analysis of response data show Values of “Prob > F” less than 0.0500 indicate radiation is significant model terms. The peak optical density increased proportionately, that is mainly due to the high production of nanoparticles [82, 83]. Optimization of lupin-Se-NPs production using general factorial design was previously discussed [14]. Gamma ray improve metallic nanoparticles synthesis in presence of plant extract [84], this attributed to potent reducing free electron generated from radiation that assist reduction of ions to metallic nanoparticles [85, 86].
The conditions 1 × 102 µg/ml Ag-nitrate, 5kGy and 2 × 102 µg/ml Carthamus dry extract, with change in gamma radiation dose by increase or decrease the dose show negative effect on Ag-Carth-NPs production (Figure 1a). This attributed to increase in random movement of particles in Ag-Carth-NPs suspension, that associate with increase of gamma doses leading to Ag-Carth-NPs aggregation and precipitation [86], or decrease in Ag-Carth-NPs production that associated with decrease in gamma radiation due to low level of free electron production that responsible for silver reduction [85].
Ag-Carth-NPs validation and stability
UV-Vis spectrophotometry: For the first validation of metallic nanoparticle production, UV Vis spectrophotometry is an essential tool [87]. The UV-Vis spectrum of Ag-Carth-NPs (Figure 1a) showed the highest absorption peaks at 425nm in solutions, which indicate the localized surface Plasmon resonance (LSPR) characteristics of silver nanoparticles [88]. Smaller nanoparticles absorb light primarily and have peaks that are near 400 nm, whereas larger particles show more scattering and have peaks that broaden and shift toward longer wavelengths (a process called red-shifting) [89]. Figure 1a show that, Ag-Carth-NPs UV-Vis spectrum at 0kGy, 10kGy at 1 × 102µg/ml Ag-nitrate and 2 × 102 µg/ml Carthamus dry extract has the same peak wavelength 425 nm with decrease in optical density (1.7±0.031 and 3.23±0.161 respectively) compering with 5kGy (4.42±0.21), this indicates low Ag-Carth-NPs production with decrease or increase of gamma radiation dose. Where increase in optical density corresponds with a dosage of gamma rise from 0 to 5kGy and then decreased with 10kGy. an increase in peak intensity, indicating a decrease in particle size and an increase in NPs production[85]. The results from UV-Vis spectrum of Ag-Carth-NPs and general factorial design optical density response confirm gamma radiation has significant effect on Ag-Carth-NPs production yield and the optimum dose is 5kGy.
The particle size distribution and zeta potential of Ag-Carth-NPs in water dispersion was measured by DLS technique [90]. Ag-Carth-NPs size distribution was found at range 32.00 nm (Figure 1b). Dynamic Light Scattering (DLS) estimates the hydrodynamic diameter of dissolved nanoparticles and gives insights on their aggregated state [91]. Size dispersed particle averages of DLS values are slightly greater than TEM values. Because, DLS you measure hydration sphere diameter where there will be solvent molecules associated with your particle [92].
Zeta potential is it an important tool for understanding the state of the nanoparticle surface and predicting the long term stability of a colloidal dispersion [93]. Figure 1c show Zeta potential of Ag-Carth-NPs at range about − 43±0.12 mV. The negative zeta potential indicated the stability of the nanoparticles and prevent them from agglomeration[94]. According to previously published research, nanoparticles that have a zeta potential less than – 30 mV are thought to be highly stable in the dispersion medium [95].
Transmission electron microscopy (TEM) it’s a quantitative technique to determine the particle size, shape and distribution [96]. The TEM images clearly demonstrated the Ag-Carth-NPs has spherical isotropic shape and anisotropic particles, with average particle sizes ranging 20 ± 1.22 nm (Figure 1d). TEM results are based on a number analysis of a dry particle and the values tend to be smaller than DLS results [97], this because TEM reveals the structure of molecule from interior and gives thought approximately molecule diameter and framework structure in solid case [98]. The presence of Carthamus extract act as capping and stabilizing agents that prevents the aggregation and agglomeration of generated Ag-Carth-NPs.
FTIR spectrum is used to identify the functional groups used in capping of NPs [99]. FT-IR spectrum (Figure 1e) evidences the presence of different functional groups of biomolecules participated in stabilization NPs [100]. Accordingly, the FTIR spectrum of the Carthamus extract exhibited several peaks around 3520, 3020, 2630, 1170 and 890 cm−1 that indicate presence of (O-H), (N-H), (C-O) and (RCOO) function moiety. These characteristic bands predict that in the extract there are structures as proteins, polysaccharides/sugars and phenolic compounds, mainly flavonoids[101]. Results of FT-IR Ag-Carth-NPs analysis shows absorption peak at 620 cm-1 corresponding to presence of AgNPs [102], that absent from Carthamus extract. The FTIR results we can conclude that some of the biological compounds from Carthamus extract formed a strong capping agent on the AgNPs for their stabilization.
Figure 1f illustrates the XRD pattern for Ag-Carth-NPs, which showed several peaks related to Ag-Carth-NPs. Within 2 h (degree), the diffraction characteristics are 37.04, 43.11, 65.31, and 76.51, respectively. These peaks correspond to the Bragg’s reflections (111), (200), (220), and (311) planes. This suggests that silver nanoparticles have a face-centered cubic (fcc) crystalline structure [59]. The XRD pattern shows amorphous regions before 30.0 degree of 2 theta, its due to presence of biological extract [103].
The stability of Ag-Carth-NPs over a range of time was estimate firstly using UV-vis spectroscopy (Figure 1g), the intensity and sharpness of peak and location has no changed after 30 day of storage this indicate highest stability and no changes in size or distribution of nanoparticles [104, 105]. Peak intensity of Ag-Carth-NPs are slightly decreased with time increased after 60 day up to 240 day with no changes in wavelength location or sharpness, this indicate slightly aggregation of NPs [106].The stability of Ag-Carth-NPs is also estimated by DLS and zeta potential (Table 2), that show Ag-Carth-NPs has DLS size distribution at range from 32.00 ± 1.55 nm to 37.51 ± 1.71 nm at time storage ranged from 1 to 240 day with zeta potential ranged from – 43 ± 0.12 to -47±0.81 mV and Polydispersity index value at range from 0.211 ± 0.05 to 0.321 ± 0.09. These results confirm high stability of Ag-Carth-NPs over longer time with no significant changes in size with time storage.
Antimicrobial activity of Ag-Carth-NPs
Inhibition zone, MIC, MBC and Mechanism of action
Natural compounds have distinct antibacterial activities against both gram-positive and gram-negative bacteria [107]. Using biogenic synthesis to create nanoparticles (NPs) through the redox balance of an natural active substance with metal is one method of enhancing antimicrobial action [108]. In this study, the inhibition zone values of AgNO3, Carthamus extract, and Ag-Carth-NPs were represent in (Figure 2a) in compere with positive control (Clindamycin for bacteria and Nystatin for fungi. The diameter of the inhibition zone demonstrated the antibacterial activity of Ag-Carth-NPs against the examined microorganisms, which was found to be more significant than AgNO3, Carthamus extract. P. aeruginosa is the most common gram-negative pathogen causing multidrug resistant infections [109]. The results showed that the P. aeruginosa strain is more resistant to clindamycin antibiotic disc and is also the most susceptible strain to the Ag-Carth-NPs. Inhibition zone values of Ag-Carth-NPs are 23 ± 0.17, 21.0 ± 0.14, 27.0 ± 0.30, 22.0 ± 0.13, 26.0 ± 0.19, 24.0 ± 0.12, 21.0 ± 0.15 and 23.0 ± 0.14 against E. coli, K. pneumonia, P. aeruginosa, B. subtilis, S. aureus, S. epidermidis, C. tropicalis and C. albicans respectively.
A further investigation in estimating the antibacterial activity was performed by determining the MIC and MBC (Table 3). The MIC of Ag-Carth-NPs was defined as the lowest concentration at which significant inhibition of bacterial growth was achieved. P. aeruginosa revealed an MIC value of 3.126 µgml−1 for Ag-Carth-NPs, >100 µgml−1 for AgNO3 and 100 µgml−1 for Carthamus extract, in that more potent inhibition has been observed in the case of Ag-Carth-NPs against all tested organism. The results show Ag-Carth-NPs has MIC at 6.25 ± 1.05 µgml−1 for E. coli and K. pneumonia, 12.5 ± 1.051 µgml−1 for S. aureus, S. epidermidis and C. albicans and 25 ± 1.071 µgml−1 for B. subtilis and C. tropicalis. Previous study demonstrated MIC of myco-synthesized silver nanoparticles for different bacterial strains was 1.5625 µg/ml for Listeria and Shigella, 0.78125 for E. coli and 3.125 for S. typhi[110]. The MICof AgNPs against S. aureus was 2.5 µg/disc and less than 2.5 µg/disc for P. aeruginosa[111]. Other studies refer biogenic AgNPs showed antimicrobial activities against gram-positive and gram-negative bacteria at MIC ranged between 16 and 64 μg ml−1[112].
The lowest concentration of NPs that was bactericidal, i.e. that showed no growth on agar plates, was selected as MBC. In this study, for P. aeruginosa in case of Ag-Carth-NPs the MBC was 6.25 µgml−1. In case of other tested organisms Ag-Carth-NPs showed bactericidal activity at 12.5 for both E. coli and K. pneumonia and 25 µgml−1 for S. aureus, S. epidermidis and C. albicans and 50 µgml−1 for B. subtilis and C. tropicalis. Previous study refer to biogenic silver nanoparticles has MBC values against P. aeruginosa 27853 and S. aureus 25923 at 12 μg ml−1 and 3 μg ml−1 for E. coli 35218 [113]. The biogenic silver nanoparticles were found to be more potent bactericidal agents at low concentration [114].
Previous study indicates that majority of the examined bacteria were not inhibited in growth by aqueous extracts of safflower, with the exception of Acinetobacter baumannii, for which the inhibition zone measured two millimeters [115]. The antibacterial properties of silver nanoparticles synthesized from plant extract may have different processes when applied to gram positive and gram negative cells, where production of reactive oxygen species (ROS), radicals OH and hydrogen peroxide, is one of those mechanisms [116]. Especially when it involves gram-negative bacteria, reactive oxygen species cause oxidative stress and target the lipids in the outer membrane, leading to lipid oxidation, damage to proteins, RNA, and DNA, and ultimately, cell death [117]. Fecal microbiota transplantation has been proposed as a potential therapeutic solution [118] Several authors have reported that the microbial activity of AgNPs measuring 20–80 nm was attributed to the release of silver ions [119].
Silver nanoparticles, are recognized as a superior antibacterial agent than other metallic nanoparticles or antimicrobial agents that can fight both in vivo and in vitro microbes that cause diseases [120]. AgNPs have the ability to combat both gram-positive and gram-negative bacteria and fungi, including those that are resistant to multiple drugs [121]. AgNPs have several simultaneous modes of action. They have also demonstrated a synergistic effect against pathogen microbes when combined with antimicrobial agents or antibiotics [122]. Due to their unique properties, silver nanoparticles can be effectively used to cure or prevent infections in a variety of medical and healthcare goods [123]. Advantages of using AgNPs as new antibacterial agents in combination with antibiotic, which will reduce the dosage needed and prevent secondary effects associated to both [124].
Proposal antimicrobial Mechanisms of Ag-Carth-NPs Ag-Carth-NPs It is very likely that it has the same mechanism as the AgNPs. Different hypotheses for antimicrobial mechanism of AgNPs are discussed, including (i) Penetrating bacterial membrane, causing the cell membrane to be destroyed and content to spill out [125]. (ii) disrupt DNA structure, or directly contact with DNA to cause DNA mutations and disrupt DNA replication [126], (iii) Generating ROS and disabling the respiratory chains and iv) Inactivating enzymes and denaturing proteins [127]. AgNPs exhibit good antifungal properties against Candida spp. and resistant fungus. For instance, AgNPs may influence drug sensitivities by targeting many cellular targets of Candida albicans, such as fatty acids like oleic acid, which are crucial for the hyphal morphogenesis responsible for the pathogenicity [128]. AgNPs may be able to bind to and saturate the fungal hypoha, ultimately rendering the fungus inactive [129]. AgNPs have been proven to effectively inhibit various pathogenic bacteria, fungi and viruses, including gram positive and negative bacteria and fungi and viruses [29, 130]. Some factors can effect on antimicrobial activity of AgNPs such as bacteria strains, size, shape and concentration of AgNPs, time contact, and surface charge of particles [131]. AgNPs with larger surface has larger reaction surface, show stronger antibacterial activity [132]. Microorganism surfaces typically exhibit negative charge [133]. Antimicrobial activity of AgNPs is also affected by the surface charge, so positive charge can facilitate the adherence of Ag-NPs on bacterial membranes through electrostatic attraction [134]. Therefore, adjusting the surface charges of AgNPs may contribute to the enhanced antibacterial effect [135].
Surface interactions between polyphenols and newly reduced metallic silver particles function as the capping factor preventing the agglomeration of AgNPs [136]. Combining silver nanoparticles and plant extracts against microbes has drawn attention within the past few years [137]. Synergistic effect of plant extracts and silver nanoparticles allowed for efficacy higher than that of antibiotics (ampicillin) when tested at the same concentrations and after a relatively short exposure time of 3 h [138]. Preparation of silver nanoparticles in combination with C. tenuis extract in form of Ag-Carth-NPs, it is a preferred method and has a strong effect on all tested microbes.
Nanomaterials are used in a variety of biomedical applications, including anticancer therapeutics, antiviral applications, antibacterial and antifungal applications, wound healing, and antitumor activity [139, 140]. Green synthesis methods for silver nanoparticles are currently being developed by researchers and are beneficial for biomedical applications [141, 142]. Because unique characteristics of Ag-NPs such as their higher surface to volume ratio, a wide surface area, strong surface Plasmon resonance, stability, ease of processing, and multi-functionalization are well suited for a variety of biological applications such as antibacterial, antifungal applications, wound healing, target therapy and antitumor activity [133]. Silver nanoparticles, however, have a lot of interesting potential for use in biomedical applications, such as coatings for medical devices, formulations, drug administration, detection and diagnosis platforms, and biomaterials [143].
Biofilm inhibition
Microbes producing biofilms are the cause of numerous diseases. According to one study by the Centers for Disease Control and the National Institutes of Health, between 65 and 80% of infections were caused by bacteria producing biofilms [144]. The biofilm inhibitory activities of the Ag-Carth-NPs were performed using crystal violet assay. The Ag-Carth-NPs showed significant reduction in the biofilm formation compared to silver nitrate and Carthamus extract (positive control) as shown in (Figure 3). It was observed that Ag-Carth-NPs were able to reduce the biofilm formed by E. col, K. pneumonia, P. aeruginosa, B. subtilis, S. aureus, S. epidermidis, C. tropicalis and C. albicans are 62.12, 68.25, 90.12, 69.51, 70.61, 71.12, 75.51 and 77.71 %, respectively at 0.75MIC and 40.21, 45.51, 62.12, 42.12, 47.3, 43.61, 48.21 and 49.6% at 0.5MIC and 30.31, 34.5, 38.32, 31.61, 33.21, 32.41, 35.41 and 31.61% at 0.25MIC respectively.
The negative controls is experiment tubes containing media alone represented no growth or biofilm formation in the other hand negative controls is experiment tube contain media plus tested organisms in absence of Ag-Carth-NPs represented microbial biofilm formation without any percent of biofilm formation inhibition. Ag-Carth-NPs have significant inhibition of biofilm formation in compere with AgNO3 and Carthamus extract. AgNPs (10 µg/ml) synthesized by plant extract of G. lanceolarium were used to treat P. aeruginosa for 24 hours, resulting in a >99% reduction in biofilm formation[145]. Ag-NPs significantly eradicated mature biofilms developed by A. baumannii, K. pneumoniae and P. aeruginosa standard strains and clinical isolates[146]. Ag-NPs exhibited reduction in biofilm formation at range 22–79, 29–87, 12–59, 22–63, and 17–81% against P. aeruginosa, E. coli, C. violaceum, K. pneumoniae, and S. aureus respectively at sub-MICs ranging from 1/16 × MIC-1/2 × MIC[147]. Previous study reported biogenic synthesized AgNPs resulted in an 89% inhibition of biofilm formation in S. aureus and 75% in E. coli [145].
Prior research regarding the anti-biofilm effects of biosynthesized AgNPs against P. aeruginosa and S. epidermidis has been done by S. Kalishwaralal et al. [66]. The synergistic activity of the AgNPs and plant extract to control the biofilm formation by the pathogenic organisms are discussed by previous study [145]. The antibiofilm activity of AgNPs against P. aeruginosa, S. aureus (MRSA), S. mutans, and C. albicans was studied extensively and reported the potentiality of AgNPs [148]. Rolim et al. [149] reported the biofilm eradication of AgNPs against P. aeruginosa which supports our current results. Three pathways in particular are significant for the antibiotic resistance of bacteria in biofilms are (i) Resistance at the Biofilm Surface, (ii) Resistance in Biofilm Microenvironments and (3) Persister bacterial cells resistance [150].
Biofilm formation inhibition by Ag-NPs is due to, structural alterations of the membrane, increasing permeability and damaging membrane integrity. Furthermore, Ag-NPs adhered to the cell surface can stop the production of biofilms since bacterial adherence to any surface is the first step in the process [151]. Since Ag ions which generated from Ag-NPs after transported into the cell may interfere with microbial proteins and enzymes which are required for microbial adherences or formation of quorum sensing that resulted in the reduction in biofilm formation [152]. Physical and chemical properties of AgNPs, such as size and shape influence the activity of the nanoparticles, because smaller sizes increase the surface contact area of AgNPs with microorganisms and then decrease biofilm formation [37].
Time kill curve activity of Ag-Carth-NPs
The time kill activity of tested pathogens is done at Ag-Carth-NPs final concentration of 0 MIC, 0.5 MIC, 1 MIC, 2MIC and 4MIC and different time interval 0, 1, 2, 4 and 8 h as shown in (Figure 3). Ag-Carth-NPs were effective in inhibiting and killing the microbes in a dose and time dependent manner as shown in the time kill assays. The bactericidal activity of Ag-Carth-NPs is effective against the selected bacteria and fungi; the reduction in the number of CFU/ml is significant in compered with growth of controls (untreated bacteria/fungi refer to growth at 0MIC) that has ascending growth curve over all tested time.
The bactericidal endpoint of Ag-Carth-NPs for E. coli was reached after 1 h of incubation at 4MIC (25 µg/ml); while for K. pneumoniae, the bacteria was killed after 2 h of incubation at 2MIC (12.5 µg/ml) and after 1 h at 4MIC (25µg/ml). P. aeruginosa was killed after 1 h of incubation at 2MIC (6.25 µg/ml) and 4MIC (12.5 µg/ml). The bactericidal endpoint of Ag-Carth-NPs for B. subtilis was reached after 2 h of incubation at 2MIC (50 µg/ml) and 4MIC (100 µg/ml); however, the end point reached after 2h of incubation at 2MIC (25 µg/ml) and (100 µg/ml) for S. aureus. The bactericidal endpoint of Ag-Carth-NPs for S. epidermidis was reached after 2 h of incubation at 2 MIC (25 µg/ml) and 4MIC (50 µg/ml). C. tropicalis was killed after 2 h of incubation at 2MIC (50 µg/ml) and 4MIC (100 µg/ml); however, the bactericidal endpoint of Ag-Carth-NPs for C. albicans after 2 h of incubation at 2 MIC (25 µg/ml) and 4MIC (50 µg/ml).
The results demonstrated that Ag-Carth-NPs could completely inhibit growth of the tested microorganisms in dose dependent manner. A Significant difference was found among the tested pathogens at the time killing depend on types of organisms and concentration of Ag-Carth-NPs. However, the end point reached faster after 1h of incubation with low concentration for P. aeruginosa in competing with other tested microbes. Ag-NP concentrations and the types of bacteria used in the research have an impact on the inhibition of bacterial growth [153]. Ag-Carth-NPs exhibit significant bactericidal effect against all tested organisms, this must be due to synergistic effect of AgNPs and bioactive agent of Carthamus extract present over its surface as reported earlier with AgNPs plant extract combination [154]. Furthermore, such surface loading biochemical agents over NPs enhance solubility of NPs in aqueous suspension, thereby providing the additional benefit of increased bioavailability and therapeutic potential [155].
The killing activity of AgNPs are fast acting against all the gram negative bacteria and the reduction in the number of CFU mL-1 was >3 Log10 units (99.9%) in 1–2 h [9]. The bactericidal ability of Ag-NPs synthesized by S. polyanthum leaves extract entirely killed most foodborne pathogens after 4 h of incubation at 4 × MIC concentration [156]. AgNPs reduced the number of the bacterial cells by more than 3 log10 when compared to the initial inoculum [157]. Based on the results, the tested gram negative bacteria were able to kill in a shorter time at low concentration of Ag-Carth-NPs compere with positive bacteria and fungi. This may be attributed to the composition of bacteria's cell walls. Compared to gram positive bacteria, gram negative bacteria have a distinct cell wall structure, an outer membrane made of lipopolysaccharide, a thin layer of peptidoglycan, and a cytoplasmic membrane [158]. Due to their potent biocidal impact against pathogens, silver nanoparticles are widely recognized as among the most common antimicrobial agents [159] and AgNPs have been used as anti-fungal [160]. The smaller NPs have a higher surface area than bigger ones; they may be more bactericidal to bacteria and exhibit superior bactericidal effects because they can more easily attach to the cell wall and penetrate the bacterial cell [161].
Motility of P. aeruginosa
The sub-MIC inhibitory effect of Ag-Carth-NPs on different types of virulence factors in P. aeruginosa was investigated (Selected because is more resistant strain to control antibiotic and high sensitive to Ag-Carth-NPs). The Ag-Carth-NPs had a significant influence on the swarming, motility of P. aeruginosa when they were present at concentrations of 1.56 μg/ml as compared to the untreated controls as shown in (Figure 4a). Ag-Carth-NPs show maximum inhibition of swarming motility about 84.23% in compere with control (untreated samples). Since P. aeruginosa motility, which includes properties like swarming, promotes more biofilm development and the surface attachment process [162]. In contrast Ag-Carth-NPs showed a remarkable reduction in bacterial swimming (by 86.59%) after treatment with Ag-Carth-NPs (Figure 4b).
One potential strategy for managing biofilm and infections is to use NPs to reduce microbial motility [163]. Ag-Carth-NPs effectively reduce swarming motility at sub-MIC levels, which is similar with the previous NPs inhibitory effects when made from other natural products [164]. The biosynthesized Ag-NPs have been observed to decrease the swarming motility and biofilm formation in P. aeruginosa [147]. Silver metformin nanostructure show swarming motility inhibition by about (88.87–94.16%) [50]. The previous study demonstrated that AgNPs show 42–81 % reduction in motility behavior of P. aeruginosa [145]. It has also been shown that the sub-MIC level of Ag-Carth-NPs inhibits the formation of biofilm in P. aeruginosa, as well as inhibits the swarming motility activity.
Pyocyanin level
Treating of P. aeruginosa with Ag-Carth-NPs reduced by 78.71% (Figure 4c); Based on results of ANOVA, it was found that, the of OD value of pyocyanin produced by P. aeruginosa was significantly reduced compared to the control (untreated sample). Treatment of Pseudomonas aeruginosa with the Ag-NPs (0.5–1 μg/mL) resulted in a significant a significant decrease of production of pyocyanin [165]. In a study, Khan et al, showed that the production of P. aeruginosa PAO1 KCTC 1637 pyocyanin at gold nanoparticles concentrations of 0.032, 0.128 and 0.256 mg/ml decreased 79.4, 81.9, and 87.7%, respectively compared to the control [164]. Comparable to the findings of this investigation, demonstrated the impact of nanoparticles on decreasing P. aeruginosa pyocyanin production [166]. Thus, without influencing bacterial growth or starting resistance selection, pyocyanin decrease can be thought of as an effective way to reduce the pathogenicity and colonization of P. aeruginosa [167].
Total protease production
The ability of the Ag-Carth-NPs to inhibit proteolytic activity was measured using the modified skimmed milk broth method. It was found that the inhibitory activity of Ag-Carth-NPs is 73.8% in compere with control (Figure 4d). Proteases destroy immune globulins and fibrin as well as they disrupts epithelial tight junctions [168]. Nanoparticles has significant capability to inhibit P. aerouginosa Proteases production [169]. Significantly reduced the levels of total protease by biologically Synthesized gold and selenium Nanoparticles [48].
Virulence attenuating properties of Ag-Carth-NPs against P.aeruginosa
Conventional PCR for virulence genes screening
Upon screening of the major P. aerugenosae virulence genes, the isolate was positive for exoU, phzM, toxA and lasB showing bands at 134, 875, 396, and 1220 bp, respectively. Therefore, this clinical isolate can be identified as a hypervirulent strain (Figure 5a). Previous study confirm virulence genes, of ExoU, ExoS, phzM, toxA, and lasB genes are present in P. aeruginosa isolate [170]. The presence of different virulence genes in P. aeruginosa isolates indicates that these strains have a relationship to various levels of intrinsic pathogenicity and virulence[171]. The phz, lasB, toxA, exoS and exoU genes were detected in P. aeruginosa strains exhibit high antimicrobial resistance [172].
Assessment of the effect of of Ag-Carth-NPs genes using qRT‑PCR
The DNA extract were tested for the presence of the five exotoxin genes (lasR, exoU, phzM, toxA and lasB) in P. aeruginosa using specific primers by multiplex PCR. A variety of virulence factors play a role in the pathogenesis of P. aeruginosa [45]. The inhibition of the expression of P. aeruginosa virulence genes (lasR, exoU, phzM, toxA and lasB) were assessed by qRT-PCR after 24 h of treatment with 1.562 µg/ml Ag-Carth-NPs. The expression levels of lasR, exoU, phzM, toxA and lasB were significantly decreased after treatment with sub-MICs of the Ag-Carth-NPs compared to controls (Figure 5b). The results show, ToxA gene expression was significantly downregulated by 81.5%, while exoU gene expression reduced by 78.1%. The percentage inhibition in lasR gene expression was 68%, while the reduction in exoU was 66%. Furthermore, there was a 60.1% decrease in lasB gene expression.
Biogenic synthesized Ag-NP show a significant reduction in LasB production by P. aeruginosa [173]. The expression of QS regulatory genes (lasI, lasR, rhlI, rhlR, and fabH2) in P. aeruginosa PAO1 was suppressed by AgNPs, according to Singh et al, [174]. The combination of AgNPs and 4-nitropyridine N-oxide can inhibit the expression genes (lasI, lasR, rhlI, rhlR, pqsA, and pqsR) [175]. A significant reduction in virulence gene expression was observed with chemical synthesized AgNPs [50, 176]. Previous study refer to Ag-CNTs, the expression levels of the rpoS, rsmZ, and oprD genes were significantly down regulated in P. aeruginosa compared to the untreated samples [51]. These results suggest that the mechanism of action may be attributed to their effect on cell-membrane integrity, down regulation of virulence-gene expression, and induction of general and oxidative stress in P. aeruginosa
Ag nanoparticles (NPs), exhibits superior ion release per unit mass, essentially owing to the augmented effective surface area. The dynamic correlation between nanoscale effects and Ag(I) ions contributes to the enhanced antimicrobial efficacy of Ag-NPs compared to their bulk counterparts [177]. It raises three probable antimicrobial mechanisms in Ag-NPs, including Ag-NPs as a reservoir for Ag(I) ions, particle only effects, and synergistic effects due to the combination of the first two mechanisms [178]. Synergistic antimicrobial mechanism, in which the NPs are absorbed intracellular and endure subsequent leaching of Ag+, raising local ion concentrations, resulting in physical interference or disruption of the phospholipid cell membrane and ROS generation at the surface of cell biomolecules [179]. This leads to damage the biomolecules such as enzymes, proteins and DNA, resulting in bacterial cell death [180].
Possible strategies for Ag-Carth-NPs from the environment
There is extensive research on the application of Nano based materials and the consequences of their release into the environment. However, there is little information about environmentally friendly approaches for removing nanomaterial’s from the environment [181]. Nanomaterial’s especially AgNPs affect soil properties, microorganisms, and plants and can therefore cause toxicity for living organisms including humans. However, there is little information about environmentally friendly approaches for removing nanomaterials from the environment. The possibility of remediation of Ag-Carth-NPs using phytotechnology approaches. Phytotechnology refers to a technology that uses plants to remove, uptake, absorb, transform, transfer, attenuate, accumulate, degrade, or metabolite organic, inorganic, metallic, or metalloid contaminants from soil, water, or air [182]. The term phytotechnology refers to a group of sub-disciplines of scientific study that include phytoextraction, phytosequestration, phytovolatilization, phytodegradation, and phytoremediation. The terms phytotechnology and phytoremediation are synonymous, however the latter term usually designates a phytotechnological process that eliminates contaminants from the surrounding environment. By storing contaminants in plant biomass to assure environmental safety, phytoremediation is a natural, easy, affordable, and widely used bioremediation approach that uses the principles of a plant’s metabolic system to clean, recover, and remediate contaminated environments [183].
Cytotoxicity of Ag-Carth-NPs
The potential application of Ag-Carth-NPs as antimicrobial agent must be taken into account that it is not harmful to the normal. The results in this, Ag-Carth-NPs have no significant cytotoxic effects on normal human cell (Hfb4) at different concentration ranged from 100 to 1.56 (Figure 6) this indicates Ag-Carth-NPs are safe against human normal cells. The anticancer efficacy of Ag-Carth-NPs has been investigated against HepG-2 cells (human Hepatocellular carcinoma). As the concentrations of Ag-Carth-NPs increased, cell viability decreased, meaning cytotoxicity increased (Figure 6). Data analysis confirms that the IC50 value of Ag-Carth-NPs against HepG-2 cells is 5.6 µg/ml.
Ag-NP exposure may cause morphological abnormalities in cells, decrease viability in cells, increase the release of lactate dehydrogenase (LDH), and ultimately cause necrosis and apoptosis in cells. The direct result of AgNP-induced oxidative stress and Ag ion release is cytotoxicity [184]. Biologically synthesized Ag-NP were also proved to exhibit excellent cytotoxic effect on MCF-7 and HT-29 [185]. Human body can tolerate 0.4 to 27 μg of AgNPs per day when consumed through the oral route [186]. Human cells were found to have a greater resistance to the toxic effects of silver nanoparticles in comparison with other cells [187]. Green synthesized AgNPs are biocompatible and do not harm normally functioning human or host cells [188].
Conclusion
In the present study, a facile biological technology is used for Ag-Carth-NPs synthesis in the presence of Silver nitrate and Carthamus tenuis extract. The synthesized Ag-Carth-NPs demonstrated spherical particles with 20 ± 1.22 nm, high stability with zeta potential around – 43 mV and FTIR spectroscopy indicated the presence of various functional biological groups that responsible for stabilization of Ag-Carth-NPs. Antimicrobial results revealed that Ag-Carth-NPs has inhibition zone ranged (27 ± 0.30 to 21 ± 0.14 mm) and anti-biofilm formation activities ranged (40.21 to 90.12%) against tested bacteria and fungi. The values of MIC and MBC ranged between 3.126 and 25 and 6.25–50 μg/ml, respectively. Ag-Carth-NPs inhibit the growth of the tested microorganisms at 2MIC after times ranging from 1 h to 2 h. Furthermore Ag-Carth-NPs reduce swarming, swimming motility, pyocyanin and protease production of P. aeruginosa in comparison with the control (untreated). The results show, P. aeruginosa ToxA gene expression was significantly down regulated by 81.5%, while exoU gene expression was reduced by 78.1%. The percentage inhibition in lasR gene expression was 68%, while the reduction in exoU was 66%. Furthermore, there was a 60.1% decrease in lasB gene expression. Ag-Carth-NPs have no significant cytotoxic effects on normal human cell (Hfb4) but have IC50 at 5.6 µg/ml against of HepG-2 cells. Further carefully designed studies should be taken taking into account such as, pharmacokinetic, and formulation of gel based Ag-Carth-NPs are necessary to demonstrate the possibility usage as a promising novel drug for combating pathogenic microbes in topical form.
Availability of data and materials
The data and materials that support the findings of this study are available from the corresponding author, upon reasonable request. No datasets were generated or analysed during the current study.
References
Faisal S, Tariq MH, Abdullah, Zafar S, Un Nisa Z, Ullah R, Ur Rahman A, Bari A, Ullah K, Khan RU. Bio synthesis, comprehensive characterization, and multifaceted therapeutic applications of BSA-resveratrol coated platinum nanoparticles. Sci Rep. 2024;14:7875.
Zafar S, Faisal S, Jan H, Ullah R, Rizwan M, Abdullah, Alotaibi A, Bibi N, Rashid AU, Khattak A. Development of iron nanoparticles (FeNPs) using biomass of enterobacter: Its characterization, antimicrobial, anti-Alzheimer’s, and enzyme inhibition potential. Micromachines. 2022;13:1259.
Dhanalakshmi M, Losetty V. Investigation of antibacterial, antioxidant, cytotoxicity and photocatalytic dye degradation activity of green synthesized copper oxide nanoparticles using Ceropegia debilis plant extract. Clean Technol Environ Policy. 2024. https://doi.org/10.1007/s10098-024-02776-4.
Saqib S, Nazeer A, Ali M, Zaman W, Younas M, Shahzad A, Sunera, Nisar M. Catalytic potential of endophytes facilitates synthesis of biometallic zinc oxide nanoparticles for agricultural application. Biometals. 2022;35:967–85.
Behravan M, Panahi AH, Naghizadeh A, Ziaee M, Mahdavi R, Mirzapour A. Facile green synthesis of silver nanoparticles using Berberis vulgaris leaf and root aqueous extract and its antibacterial activity. Int J Biol Macromol. 2019;124:148–54.
Kumar B, Smita K, Cumbal L, Debut A. Green synthesis of silver nanoparticles using Andean blackberry fruit extract. Saudi J Biol Sci. 2017;24:45–50.
Ullah R, Shah S, Muhammad Z, Shah SA, Faisal S, Khattak U, Haq TU, Taj Akbar M. In vitro and in vivo applications of Euphorbia wallichii shoot extract-mediated gold nanospheres. Green Process Synth. 2021;10:101–11.
Faisal S, Abdullah, Jan H, Shah SA, Shah S, Rizwan M, Zaman N, Hussain Z, Uddin MN, Bibi N. Bio-catalytic activity of novel Mentha arvensis intervened biocompatible magnesium oxide nanomaterials. Catalysts. 2021;11:780.
Loo YY, Rukayadi Y, Nor-Khaizura MAR, Kuan CH, Chieng BW, Nishibuchi M, Radu S. In vitro antimicrobial activity of green synthesized silver nanoparticles against selected gram-negative foodborne pathogens. Front Microbiol. 2018;9:1555.
Karthik L, Kirthi AV, Ranjan S, Srinivasan VM. Biological synthesis of nanoparticles and their applications. Boca Raton: CRC Press; 2019.
Faisal S, Khan S, Abdullah, Zafar S, Rizwan M, Ali M, Ullah R, Albadrani GM, Mohamed HR, Akbar F. Fagonia cretica-mediated synthesis of manganese oxide (MnO2) nanomaterials their characterization and evaluation of their bio-catalytic and enzyme inhibition potential for maintaining flavor and texture in apples. Catalysts. 2022;12:558.
Tareq M, Khadrawy YA, Rageh MM, Mohammed HS. Dose-dependent biological toxicity of green synthesized silver nanoparticles in rat’s brain. Sci Rep. 2022;12:22642.
Antunes Filho S, Dos Santos MS, Dos Santos OAL, Backx BP, Soran M-L, Opriş O, Lung I, Stegarescu A, Bououdina M. Biosynthesis of nanoparticles using plant extracts and essential oils. Molecules. 2023;28:3060.
Mosallam FM, El-Sayyad GS, Fathy RM, El-Batal AI. Biomolecules-mediated synthesis of selenium nanoparticles using Aspergillus oryzae fermented Lupin extract and gamma radiation for hindering the growth of some multidrug-resistant bacteria and pathogenic fungi. Microb Pathog. 2018;122:108–16.
Alwhibi MS, Soliman DA, Awad MA, Rizwana H, Marraiki NA. Biosynthesis of silver nanoparticles using fenugreek seed extract and evaluation of their antifungal and antibacterial activities. J Comput Theor Nanosci. 2018;15:1255–60.
dos Santos Souza LM, Dibo M, Sarmiento JJP, Seabra AB, Medeiros LP, Lourenço IM, Kobayashi RKT, Nakazato G. Biosynthesis of selenium nanoparticles using combinations of plant extracts and their antibacterial activity. Curr Res Green Sustain Chem. 2022;5:100303.
Alshammari SO, Mahmoud SY, Farrag ES. Synthesis of green copper nanoparticles using medicinal plant Krameria sp. Root extract and its applications. Molecules. 2023;28:4629.
Farooqui MA, Chauhan PS, Krishnamoorthy P, Shaik J. Extraction of silver nanoparticles from the leaf extracts of Clerodendrum inerme. Dig J Nanomater Biostruct. 2010;5:43–9.
Vilatersana R, Garnatje T, Susanna A, Garcia-Jacas N. Taxonomic problems in Carthamus (Asteraceae): RAPD markers and sectional classification. Bot J Linn Soc. 2005;147:375–83.
Azab A. Total phenolic content, antioxidant capacity and antifungal activity of extracts of Carthamus tenuis and Cephalaria joppensis. Eur Chem Bull. 2018;7:156–61.
Kuete V, Wiench B, Hegazy MEF, Mohamed TA, Fankam AG, Shahat AA, Efferth T. Antibacterial activity and cytotoxicity of selected Egyptian medicinal plants. Plant Med. 2012;78:193–9.
Rodríguez-Félix F, López-Cota AG, Moreno-Vásquez MJ, Graciano-Verdugo AZ, Quintero-Reyes IE, Del-Toro-Sánchez CL, Tapia-Hernández JA. Sustainable-green synthesis of silver nanoparticles using safflower (Carthamus tinctorius L.) waste extract and its antibacterial activity. Heliyon. 2021. https://doi.org/10.1016/j.heliyon.2021.e06923.
Rodríguez-Félix F, Graciano-Verdugo AZ, Moreno-Vásquez MJ, Lagarda-Díaz I, Barreras-Urbina CG, Armenta-Villegas L, Olguín-Moreno A, Tapia-Hernández JA. Trends in sustainable green synthesis of silver nanoparticles using agri-food waste extracts and their applications in health. J Nanomater. 2022;2022:8874003.
Zhou XiDan ZX, Tang LiYing TL, Xu YiLong XY, Zhou GuoHong ZG, Wang ZhuJu WZ. Towards a better understanding of medicinal uses of Carthamus tinctorius L. in traditional Chinese medicine: a phytochemical and pharmacological review. J Ethnopharmacol. 2014;15:27–43.
El-Hela A, Ibrahim T, Abdel-Hady N, Al-Massarani S, Abd-Allah G. Phytochemical and biological investigation of Carthamus tenuis Boiss. growing in Egypt. Planta Med. 2013;79:PN46.
Negi PS. Plant extracts for the control of bacterial growth: Efficacy, stability and safety issues for food application. Int J Food Microbiol. 2012;156:7–17.
Davidson PM, Taylor TM, Schmidt SE. Chemical preservatives and natural antimicrobial compounds. Food Microbiol Fundam Front. 2012. https://doi.org/10.1128/9781555818463.ch30.
Lahiri D, Nag M, Sheikh HI, Sarkar T, Edinur HA, Pati S, Ray RR. Microbiologically-synthesized nanoparticles and their role in silencing the biofilm signaling cascade. Front Microbiol. 2021;12:636588.
Saqib S, Faryad S, Afridi MI, Arshad B, Younas M, Naeem M, Zaman W, Ullah F, Nisar M, Ali S. Bimetallic assembled silver nanoparticles impregnated in Aspergillus fumigatus extract damage the bacterial membrane surface and release cellular contents. Coatings. 2022;12:1505.
Saqib S, Zaman W, Ullah F, Majeed I, Ayaz A, Hussain Munis MF. Organometallic assembling of chitosan-Iron oxide nanoparticles with their antifungal evaluation against Rhizopus oryzae. Appl Organomet Chem. 2019;33: e5190.
Dhaka A, Mali SC, Sharma S, Trivedi R. A review on biological synthesis of silver nanoparticles and their potential applications. Result Chem. 2023;6:101108.
Dutt Y, Pandey RP, Dutt M, Gupta A, Vibhuti A, Raj VS, Chang C-M, Priyadarshini A. Silver nanoparticles phytofabricated through Azadirachta indica: anticancer, apoptotic, and wound-healing properties. Antibiotics. 2023;12:121.
Ahmad A, Haneef M, Ahmad N, Kamal A, Jaswani S, Khan F. Biological synthesis of silver nanoparticles and their medical applications. World Acad Sci J. 2024;6:1–9.
Yin IX, Zhang J, Zhao IS, Mei ML, Li Q, Chu CH. The antibacterial mechanism of silver nanoparticles and its application in dentistry. Int J Nanomed. 2020;15:2555–62.
Selem E, Mekky AF, Hassanein WA, Reda FM, Selim YA. Antibacterial and antibiofilm effects of silver nanoparticles against the uropathogen Escherichia coli U12. Saudi J Biol Sci. 2022;29:103457.
Barabadi H, Hosseini O, Jounaki K, Sadeghian-Abadi S, Ashouri F, Alrikabi AMA, Vahidi H, Amidi S, Mojab F, Mohammadi N. Bioinspired green-synthesized silver nanoparticles: in vitro physicochemical, antibacterial, biofilm inhibitory, genotoxicity, antidiabetic, antioxidant, and anticoagulant performance. Mater Adv. 2023;4:3037–54.
Seo M, Oh T, Bae S. Antibiofilm activity of silver nanoparticles against biofilm forming Staphylococcus pseudintermedius isolated from dogs with otitis externa. Vet Med Sci. 2021;7:1551–7.
Boakye YD, Osafo N, Danquah CA, Adu F, Agyare C. Antimicrobial agents: antibacterial agents, anti-biofilm agents, antibacterial natural compounds, and antibacterial chemicals. Antimicrob Antibiot Res Antib Strateg Activity Methods. 2019;13:75.
Mi G, Shi D, Wang M, Webster TJ. Reducing bacterial infections and biofilm formation using nanoparticles and nanostructured antibacterial surfaces. Adv Healthcare Mater. 2018;7:1800103.
Cortés ME, Bonilla JC, Sinisterra RD. Biofilm formation, control and novel strategies for eradication. Sci Against Microbial Pathog Commun Curr Res Technol Adv. 2011;2:896–905.
Strateva T, Mitov I. Contribution of an arsenal of virulence factors to pathogenesis of Pseudomonas aeruginosa infections. Ann Microbiol. 2011;61:717–32.
Høiby N, Bjarnsholt T, Givskov M, Molin S, Ciofu O. Antibiotic resistance of bacterial biofilms. Int J Antimicrob Agents. 2010;35:322–32.
Bowler PG. Antibiotic resistance and biofilm tolerance: a combined threat in the treatment of chronic infections. J Wound Care. 2018;27:273–7.
Urgancı NN, Yılmaz N, Alaşalvar GK, Yıldırım Z. Pseudomonas aeruginosa and its pathogenicity. Turk J Agric-Food Sci Technol. 2022;10:726–38.
Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7:199.
Kato J, Kim H-E, Takiguchi N, Kuroda A, Ohtake H. Pseudomonas aeruginosa as a model microorganism for investigation of chemotactic behaviors in ecosystem. J Biosci Bioeng. 2008;106:1–7.
Rocha AJ, Barsottini MRDO, Rocha RR, Laurindo MV, Moraes FLLD, Rocha SLD. Pseudomonas aeruginosa: virulence factors and antibiotic resistance genes. Braz Arch Biol Technol. 2019;62: e19180503.
Elshaer SL, Shaaban MI. Inhibition of quorum sensing and virulence factors of Pseudomonas aeruginosa by biologically synthesized gold and selenium nanoparticles. Antibiotics. 2021;10:1461.
Shah S, Gaikwad S, Nagar S, Kulshrestha S, Vaidya V, Nawani N, Pawar S. Biofilm inhibition and anti-quorum sensing activity of phytosynthesized silver nanoparticles against the nosocomial pathogen Pseudomonas aeruginosa. Biofouling. 2019;35:34–49.
Gomaa SE, Shaker GH, Mosallam FM, Abbas HA. Knocking down Pseudomonas aeruginosa virulence by oral hypoglycemic metformin nano emulsion. World J Microbiol Biotechnol. 2022;38:119.
Dosunmu E, Chaudhari AA, Singh SR, Dennis VA, Pillai SR. Silver-coated carbon nanotubes downregulate the expression of Pseudomonas aeruginosa virulence genes: a potential mechanism for their antimicrobial effect. Int J Nanomed. 2015. https://doi.org/10.2147/IJN.S85219.
Ozkan K, Bekiroglu H, Bayram Y, Sagdic O, Erbas S. In vitro bioaccessibility, antioxidant and antibacterial activities of three different safflower (Carthamus tinctorius L.) genotypes. Food Sci Technol. 2021;42: e08921.
Vladár AE, Hodoroaba V-D. Characterization of nanoparticles by scanning electron microscopy. In: Characterization of nanoparticles. Amsterdam: Elsevier; 2020. p. 7–27.
El-Batal AI, Nasser HA, Mosallam FM. Fabrication and characterization of cobalt hyaluronic acid nanostructure via gamma irradiation for improving biomedical applications. Int J Biol Macromol. 2020;147:1328–42.
El-Batal AI, Mosallam FM, El-Sayyad GS. Synthesis of metallic silver nanoparticles by fluconazole drug and gamma rays to inhibit the growth of multidrug-resistant microbes. J Cluster Sci. 2018;29:1003–15.
Sharma R, Dhillon A, Kumar D. Mentha-stabilized silver nanoparticles for highperformance colorimetric detection of Al (III) in aqueous systems. Sci rep. 2018;8:5189–202.
Badi’Ah H, Seedeh F, Supriyanto G, Zaidan A. Synthesis of silver nanoparticles and the development in analysis method. IOP Conf Ser Earth Enviro Sci. 2019;217:012005.
Sanders ER. Aseptic laboratory techniques: plating methods. JoVE J Vis Exp. 2012. https://doi.org/10.3791/3064.
Baraka A, Dickson S, Gobara M, El-Sayyad GS, Zorainy M, Awaad MI, Hatem H, Kotb MM, Tawfic A. Synthesis of silver nanoparticles using natural pigments extracted from Alfalfa leaves and its use for antimicrobial activity. Chem Pap. 2017;71:2271–81.
Mosallam FM, Helmy EA, Bendary MM, El-Batal AI. Potency of a novel synthesized Ag-eugenol nanoemulsion for treating some bacterial and fungal pathogens. J Mater Res. 2021;36:1524–37.
Abdel-Fatah SS, El-Sherbiny GM, Khalaf M, Baz AFE, El-Sayed AS, El-Batal AI. Boosting the anticancer activity of Aspergillus flavus “endophyte of Jojoba” Taxol via conjugation with gold nanoparticles mediated by γ-Irradiation. Appl Biochem Biotechnol. 2022;194:3558–81.
El-Sherbiny GM, Abou El-Nour SA, Askar AA, Mohammad NH, Hammad AA. Solar radiation-induced synthesis of bacterial cellulose/silver nanoparticles (BC/AgNPs) composite using BC as reducing and capping agent. Bioprocess Biosyst Eng. 2022;45:1–12.
Charannya S, Duraivel D, Padminee K, Poorni S, Nishanthine C, Srinivasan MR. Comparative evaluation of antimicrobial efficacy of silver nanoparticles and 2% chlorhexidine gluconate when used alone and in combination assessed using agar diffusion method: an in vitro study. Contemp Clin Dent. 2018;9:S204.
Bairagi B, Khan F, Nath D. Identification of bacterial population from diabetic wound of mice to study the bactericidal efficacy of green synthesized silver nanoparticle by saraca asoca bark extract. BioNanoSci. 2023;13:436–49.
Elbasuney S, El-Sayyad GS, Radwan SM, Correa-Duarte MA. Antimicrobial, and antibiofilm activities of silver doped hydroxyapatite: a novel bioceramic material for dental filling. J Inorg Organomet Polym Mater. 2022;32:4559–75.
Kalishwaralal K, BarathManiKanth S, Pandian SRK, Deepak V, Gurunathan S. Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis. Colloids Surf, B. 2010;79:340–4.
Tabassum N, Khan F, Jeong G-J, Oh D, Kim Y-M. Antibiofilm and antivirulence activities of laminarin-gold nanoparticles in standard and host-mimicking media. Appl Microbiol Biotechnol. 2024;108:1–15.
Ha D-G, Kuchma SL, O’Toole GA. Plate-based assay for swarming motility in Pseudomonas aeruginosa. Pseudomonas Methods Protoc. 2014;1149:67–72.
Ha D-G, Kuchma SL, O’Toole GA. Plate-based assay for swimming motility in Pseudomonas aeruginosa. Pseudomonas Methods Protoc. 2014;1149:59–65.
Wang S, Feng Y, Han X, Cai X, Yang L, Liu C, Shen L. Inhibition of virulence factors and biofilm formation by wogonin attenuates pathogenicity of Pseudomonas aeruginosa PAO1 via targeting pqs quorum-sensing system. Int J Mol Sci. 2021;22:12699.
Bogožalec Košir A, Lužnik D, Tomič V, Milavec M. Evaluation of DNA extraction methods for reliable quantification of Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Biosensors. 2023;13:463.
Winstanley C, Kaye SB, Neal TJ, Chilton HJ, Miksch S, Hart CA, Group MO. Genotypic and phenotypic characteristics of Pseudomonas aeruginosa isolates associated with ulcerative keratitis. J Med Microbiol. 2005;54:519–26.
Finnan S, Morrissey JP, O’gara F, Boyd EF. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment. J Clin Microbiol. 2004;42:5783–92.
Matar GM, Ramlawi F, Hijazi N, Khneisser I, Abdelnoor AM. Transcription levels of Pseudomonas aeruginosa exotoxin A gene and severity of symptoms in patients with otitis externa. Curr Microbiol. 2002;45:350–4.
Mukherjee K, Tribedi P, Chowdhury A, Ray T, Joardar A, Giri S, Sil AK. Isolation of a Pseudomonas aeruginosa strain from soil that can degrade polyurethane diol. Biodegradation. 2011;22:377–88.
El-Azzouny MM, El-Demerdash AS, Seadawy HG, Abou-Khadra SH. Antimicrobial effect of garlic (Allium sativum) and thyme (Zataria multiflora Boiss) extracts on some food borne pathogens and their effect on virulence gene expression. Cell Mol Biol. 2018;64:79–86.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2− ΔΔCT method. Methods. 2001;25:402–8.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65:55–63.
Liu F-K, Hsu Y-C, Tsai M-H, Chu T-C. Using γ-irradiation to synthesize Ag nanoparticles. Mater Lett. 2007;61:2402–5.
Bayik GD, Baykal B. Optimization of green synthesis parameters of silver nanoparticles with factorial design for dye removal. Gazi Univ J Sci Part A: Eng Innov. 2023;10:327–40.
Hanora A, Ghorab M, El-Batal AI, Mosalam FA. Synthesis and characterization of gold nanoparticles and their anticancer activity using gamma radiation. J Chem Pharm Res. 2016;8:405–23.
Huang H, Yang X. Synthesis of polysaccharide-stabilized gold and silver nanoparticles: a green method. Carbohyd Res. 2004;339:2627–31.
Bar H, Bhui DK, Sahoo GP, Sarkar P, De SP, Misra A. Green synthesis of silver nanoparticles using latex of Jatropha curcas. Colloids Surf, A. 2009;339:134–9.
El-Batal AI, Al-Hazmi NE, Mosallam FM, El-Sayyad GS. Biogenic synthesis of copper nanoparticles by natural polysaccharides and Pleurotus ostreatus fermented fenugreek using gamma rays with antioxidant and antimicrobial potential towards some wound pathogens. Microb Pathog. 2018;118:159–69.
El-Batal AI, Mosalam FM, Ghorab M, Hanora A, Elbarbary AM. Antimicrobial, antioxidant and anticancer activities of zinc nanoparticles prepared by natural polysaccharides and gamma radiation. Int J Biol Macromol. 2018;107:2298–311.
Mosalam M, Marzouk F. Effect of gamma radiation on the microbial synthesis of metal nanoparticles. 2013.
Campos EA, Pinto DVBS, Oliveira JISD, Mattos EDC, Dutra RDCL. Synthesis, characterization and applications of iron oxide nanoparticles-a short review. J Aerosp Technol Manag. 2015;7:267–76.
Agustina TE, Handayani W, Imawan C: The UV-VIS spectrum analysis from silver nanoparticles synthesized using Diospyros maritima blume. Leaves extract. In: 3rd KOBI Congress, International and National Conferences (KOBICINC 2020). Atlantis Press; 2021: 411–419.
González A, Noguez C. Optical properties of silver nanoparticles. Phys Stat Sol C. 2007;4:4118–26.
Varenne F, Botton J, Merlet C, Vachon J-J, Geiger S, Infante IC, Chehimi MM, Vauthier C. Standardization and validation of a protocol of zeta potential measurements by electrophoretic light scattering for nanomaterial characterization. Colloids Surf, A. 2015;486:218–31.
Brar SK, Verma M. Measurement of nanoparticles by light-scattering techniques. TrAC, Trends Anal Chem. 2011;30:4–17.
Maguire CM, Rösslein M, Wick P, Prina-Mello A. Characterisation of particles in solution–a perspective on light scattering and comparative technologies. Sci Technol Adv Mater. 2018;19:732–45.
Bhattacharjee S. DLS and zeta potential–what they are and what they are not? J Control Release. 2016;235:337–51.
Raja S, Ramesh V, Thivaharan V. Green biosynthesis of silver nanoparticles using Calliandra haematocephala leaf extract, their antibacterial activity and hydrogen peroxide sensing capability. Arab J Chem. 2017;10:253–61.
Erdogan O, Abbak M, Demirbolat GM, Birtekocak F, Aksel M, Pasa S, Cevik O. Green synthesis of silver nanoparticles via Cynara scolymus leaf extracts: the characterization, anticancer potential with photodynamic therapy in MCF7 cells. PLoS ONE. 2019;14: e0216496.
Padhi S, Behera A. Biosynthesis of silver nanoparticles: synthesis, mechanism, and characterization. In: Agri-waste and microbes for production of sustainable nanomaterials. Amsterdam: Elsevier; 2022. p. 397–440.
Tuoriniemi J, Johnsson ACJ, Holmberg JP, Gustafsson S, Gallego-Urrea JA, Olsson E, Pettersson JB, Hassellöv M. Intermethod comparison of the particle size distributions of colloidal silica nanoparticles. Sci Technol Adv Mater. 2014;15:035009.
Salvi VR, Pawar P. Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier. J Drug Deliv Sci Technol. 2019;51:255–67.
Baran MF. Green synthesis, characterization and antimicrobial activity of silver nanoparticles (AgNPs) from maize (Zea mays L.). Dergi. 2019;6:165–73.
Shah S, Shah SA, Faisal S, Khan A, Ullah R, Ali N, Bilal M. Engineering novel gold nanoparticles using Sageretia thea leaf extract and evaluation of their biological activities. J Nanostructure Chem. 2022;12:129–40.
Stan M, Popa A, Toloman D, Silipas T-D, Vodnar DC. Antibacterial and antioxidant activities of ZnO nanoparticles synthesized using extracts of Allium sativum, Rosmarinus officinalis and Ocimum basilicum. Acta Metallurgica Sinica (Engl Lett). 2016;29:228–36.
Chen Y, Cao J, Wei H, Wu Z, Wang X, Pei Y. Synthesis of polyvinyl alcohol/Ag electrospun nanofibers as highly efficient flexible SERS substrates. Vib Spectrosc. 2021;114:103246.
Nyabola A, Kareru P, Madivoli E, Wanakai S, Maina EG. Formation of silver nanoparticles via Aspilia pluriseta extracts their antimicrobial and catalytic activity. J Inorg Organomet Polym Mater. 2020;30:3493–501.
Mosallam FM, Helmy EA, Nasser HA, El-Batal AI. Novel griseofulvin zinc nanohybrid emulsion for intensifying the antimicrobial control of dermatophytes and some opportunistic pathogens. J Med Mycol. 2024;34:101489.
Unterweger H, Dézsi L, Matuszak J, Janko C, Poettler M, Jordan J, Bäuerle T, Szebeni J, Fey T, Boccaccini AR. Dextran-coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging: evaluation of size-dependent imaging properties, storage stability and safety. Int J Nanomed. 2018;13:1899–915.
Hoang V-T, Mai M, Thi Tam L, Vu NP, Tien Khi N, Dinh Tam P, Quang Huy T, Le A-T, Xuan Dinh N, Tran V-H. Functionalized-AgNPs for long-term stability and its applicability in the detection of manganese Ions. Adv Polym Technol. 2020;2020:9437108.
Semeniuc CA, Pop CR, Rotar AM. Antibacterial activity and interactions of plant essential oil combinations against gram-positive and gram-negative bacteria. J Food Drug Anal. 2017;25:403–8.
Susanti D, Haris MS, Taher M, Khotib J. Natural products-based metallic nanoparticles as antimicrobial agents. Front Pharmacol. 2022;13:895616.
Sung K, Chon J, Kweon O, Nho S, Kim S, Park M, Paredes A, Lim J-H, Khan SA, Phillips KS. Dynamic adaptive response of Pseudomonas aeruginosa to clindamycin/rifampicin-impregnated catheters. Antibiotics. 2021;10:752.
Sharma A, Sagar A, Rana J, Rani R. Green synthesis of silver nanoparticles and its antibacterial activity using fungus Talaromyces purpureogenus isolated from Taxus baccata Linn. Micro and Nano Systems Letters. 2022;10:2.
Mostafa AA, Sayed SR, Solkamy EN, Khan M, Shaik MR, Al-Warthan A, Adil SF. Evaluation of biological activities of chemically synthesized silver nanoparticles. J Nanomater. 2015;2015:789178.
Trzcińska-Wencel J, Wypij M, Rai M, Golińska P. Biogenic nanosilver bearing antimicrobial and antibiofilm activities and its potential for application in agriculture and industry. Front Microbiol. 2023;14:1125685.
Kora AJ, Sashidhar RB. Antibacterial activity of biogenic silver nanoparticles synthesized with gum ghatti and gum olibanum: a comparative study. J Antibiot. 2015;68:88–97.
Kora AJ, Sashidhar R. Biogenic silver nanoparticles synthesized with rhamnogalacturonan gum: Antibacterial activity, cytotoxicity and its mode of action. Arab J Chem. 2018;11:313–23.
Abdel Moneim E, Sherif M, Ahmed A, Mohanad A, Vajid N. Evaluation of antimicrobial activity of safflower (Carthamus tinctorius) and its synergistic effect with antibiotic. EC Microbiol. 2018;14:160–6.
Le Ouay B, Stellacci F. Antibacterial activity of silver nanoparticles: a surface science insight. Nano Today. 2015;10:339–54.
Chen S, Guo Y, Zhong H, Chen S, Li J, Ge Z, Tang J. Synergistic antibacterial mechanism and coating application of copper/titanium dioxide nanoparticles. Chem Eng J. 2014;256:238–46.
Hu B, Das P, Lv X, Shi M, Aa J, Wang K, Duan L, Gilbert JA, Nie Y, Wu X-L. Effects of ‘healthy’fecal microbiota transplantation against the deterioration of depression in fawn-hooded rats. Msystems. 2022;7:e00218-00222.
Salomoni R, Léo P, Montemor A, Rinaldi B, Rodrigues M. Antibacterial effect of silver nanoparticles in Pseudomonas aeruginosa. Nanotechnol Sci Appl. 2017;10:115–21.
Bruna T, Maldonado-Bravo F, Jara P, Caro N. Silver nanoparticles and their antibacterial applications. Int J Mol Sci. 2021;22:7202.
Sheng Y, Narayanan M, Basha S, Elfasakhany A, Brindhadevi K, Xia C, Pugazhendhi A. In vitro and in vivo efficacy of green synthesized AgNPs against gram negative and gram positive bacterial pathogens. Process Biochem. 2022;112:241–7.
Ayaz M, Ullah F, Sadiq A, Ullah F, Ovais M, Ahmed J, Devkota HP. Synergistic interactions of phytochemicals with antimicrobial agents: potential strategy to counteract drug resistance. Chem Biol Interact. 2019;308:294–303.
Almatroudi A. Silver nanoparticles: synthesis, characterisation and biomedical applications. Open life sciences. 2020;15:819–39.
Franci G, Falanga A, Galdiero S, Palomba L, Rai M, Morelli G, Galdiero M. Silver nanoparticles as potential antibacterial agents. Molecules. 2015;20:8856–74.
Qing Y, Cheng L, Li R, Liu G, Zhang Y, Tang X, Wang J, Liu H, Qin Y. Potential antibacterial mechanism of silver nanoparticles and the optimization of orthopedic implants by advanced modification technologies. Int J Nanomed. 2018;13:3311–27.
Gurunathan S, Qasim M, Park C, Yoo H, Kim J-H, Hong K. Cytotoxic potential and molecular pathway analysis of silver nanoparticles in human colon cancer cells HCT116. Int J Mol Sci. 2018;19:2269.
Wang L, Xu H, Gu L, Han T, Wang S, Meng F. Bioinspired synthesis, characterization and antibacterial activity of plant-mediated silver nanoparticles using purple sweet potato root extract. Mater Technol. 2016;31:437–42.
Jangjou A, Zareshahrabadi Z, Abbasi M, Talaiekhozani A, Kamyab H, Chelliapan S, Vaez A, Golchin A, Tayebi L, Vafa E. Time to conquer fungal infectious diseases: employing nanoparticles as powerful and versatile antifungal nanosystems against a wide variety of fungal species. Sustainability. 2022;14:12942.
Radhakrishnan VS, Reddy Mudiam MK, Kumar M, Dwivedi SP, Singh SP, Prasad T. Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (Candida albicans). Int J Nanomed. 2018;13:2647–63.
Xu L, Wang Y-Y, Huang J, Chen C-Y, Wang Z-X, Xie H. Silver nanoparticles: synthesis, medical applications and biosafety. Theranostics. 2020;10:8996.
Kumari M, Pandey S, Giri VP, Bhattacharya A, Shukla R, Mishra A, Nautiyal C. Tailoring shape and size of biogenic silver nanoparticles to enhance antimicrobial efficacy against MDR bacteria. Microb Pathog. 2017;105:346–55.
Hong X, Wen J, Xiong X, Hu Y. Shape effect on the antibacterial activity of silver nanoparticles synthesized via a microwave-assisted method. Environ Sci Pollut Res. 2016;23:4489–97.
Jiang M, Chen S, Lu X, Guo H, Chen S, Yin X, Li H, Dai G, Liu L. Integrating genomics and metabolomics for the targeted discovery of new cyclopeptides with antifungal activity from a marine-derived fungus Beauveria felina. J Agric Food Chem. 2023;71:9782–95.
Abbaszadegan A, Ghahramani Y, Gholami A, Hemmateenejad B, Dorostkar S, Nabavizadeh M, Sharghi H. The effect of charge at the surface of silver nanoparticles on antimicrobial activity against gram-positive and gram-negative bacteria: a preliminary study. J Nanomater. 2015;2015:720654.
Mandal D, Dash SK, Das B, Chattopadhyay S, Ghosh T, Das D, Roy S. Bio-fabricated silver nanoparticles preferentially targets gram positive depending on cell surface charge. Biomed Pharmacother. 2016;83:548–58.
Rolim WR, Pelegrino MT, de Araújo LB, Ferraz LS, Costa FN, Bernardes JS, Rodigues T, Brocchi M, Seabra AB. Green tea extract mediated biogenic synthesis of silver nanoparticles: characterization, cytotoxicity evaluation and antibacterial activity. Appl Surf Sci. 2019;463:66–74.
Bémer P, Plouzeau C, Tande D, Léger J, Giraudeau B, Valentin AS, Jolivet-Gougeon A, Vincent P, Corvec S, Gibaud S. Evaluation of 16S rRNA gene PCR sensitivity and specificity for diagnosis of prosthetic joint infection: a prospective multicenter cross-sectional study. J Clin Microbiol. 2014;52:3583–9.
Raza S, Wdowiak M, Grotek M, Adamkiewicz W, Nikiforow K, Mente P, Paczesny J. Enhancing the antimicrobial activity of silver nanoparticles against ESKAPE bacteria and emerging fungal pathogens by using tea extracts. Nanos Adv. 2023;5:5786–98.
Naganthran A, Verasoundarapandian G, Khalid FE, Masarudin MJ, Zulkharnain A, Nawawi NM, Karim M, Che Abdullah CA, Ahmad SA. Synthesis, characterization and biomedical application of silver nanoparticles. Materials. 2022;15:427.
Khan MA, Ali F, Faisal S, Rizwan M, Hussain Z, Zaman N, Afsheen Z, Uddin MN, Bibi N. Exploring the therapeutic potential of Hibiscus rosa sinensis synthesized cobalt oxide (Co3O4-NPs) and magnesium oxide nanoparticles (MgO-NPs). Saudi J Biol Sci. 2021;28:5157–67.
Meher A, Tandi A, Moharana S, Chakroborty S, Mohapatra SS, Mondal A, Dey S, Chandra P. Silver nanoparticle for biomedical applications: a review. Hybrid Adv. 2024;6:100184.
Faisal S, Jan H, Shah SA, Shah S, Khan A, Akbar MT, Rizwan M, Jan F, Wajidullah, Akhtar N. Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous fruit extracts of Myristica fragrans: their characterizations and biological and environmental applications. ACS Omega. 2021;6:9709–22.
Pasparakis G. Recent developments in the use of gold and silver nanoparticles in biomedicine. Wiley interdiscip Rev Nanomed Nanobiotechnol. 2022;14: e1817.
Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA. Bacterial biofilm and associated infections. J Chin Med Assoc. 2018;81:7–11.
Mohanta YK, Biswas K, Jena SK, Hashem A, Abd_Allah EF, Mohanta TK. Anti-biofilm and antibacterial activities of silver nanoparticles synthesized by the reducing activity of phytoconstituents present in the Indian medicinal plants. Front Microbiol. 2020;11:1143.
Elshaer S, Shaaban MI. Antibiofilm activity of biosynthesized silver and copper nanoparticles using Streptomyces S29. AMB Express. 2023;13:139.
Hussain A, Alajmi MF, Khan MA, Pervez SA, Ahmed F, Amir S, Husain FM, Khan MS, Shaik GM, Hassan I. Biosynthesized silver nanoparticle (AgNP) from Pandanus odorifer leaf extract exhibits anti-metastasis and anti-biofilm potentials. Front Microbiol. 2019;10:8.
Martinez-Gutierrez F, Boegli L, Agostinho A, Sánchez EM, Bach H, Ruiz F, James G. Anti-biofilm activity of silver nanoparticles against different microorganisms. Biofouling. 2013;29:651–60.
Rolim WR, Lamilla C, Pieretti JC, Díaz M, Tortella GR, Cristina Diez M, Barrientos L, Seabra AB, Rubilar O. Comparison of antibacterial and antibiofilm activities of biologically synthesized silver nanoparticles against several bacterial strains of medical interest. Energy, Ecol Environ. 2019;4:143–59.
Weber DJ, Rutala WA, Anderson DJ, Sickbert-Bennett EE. Biofilms on medical instruments and surfaces: do they interfere with instrument reprocessing and surface disinfection. Am J Infect Control. 2023;51:A114–9.
Mikhailova EO. Silver nanoparticles: mechanism of action and probable bio-application. J Funct Biomater. 2020;11:84.
Joshi AS, Singh P, Mijakovic I. Interactions of gold and silver nanoparticles with bacterial biofilms: molecular interactions behind inhibition and resistance. Int J Mol Sci. 2020;21:7658.
Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteria. J Colloid Interface Sci. 2004;275:177–82.
Bagur H, Poojari CC, Melappa G, Rangappa R, Chandrasekhar N, Somu P. Biogenically synthesized silver nanoparticles using endophyte fungal extract of Ocimum tenuiflorum and evaluation of biomedical properties. J Cluster Sci. 2020;31:1241–55.
Verma VC, Kharwar RN, Gange AC. Biosynthesis of antimicrobial silver nanoparticles by the endophytic fungus Aspergillus clavatus. Nanomedicine. 2010;5:33–40.
Khan S, Rukayadi Y, Jaafar AH, Ahmad NH. Antibacterial potential of silver nanoparticles (SP-AgNPs) synthesized from Syzygium polyanthum (Wight) Walp. against selected foodborne pathogens. Heliyon. 2023;9: e22771.
Malawong S, Thammawithan S, Sirithongsuk P, Daduang S, Klaynongsruang S, Wong PT, Patramanon R. Silver nanoparticles enhance antimicrobial efficacy of antibiotics and restore that efficacy against the melioidosis pathogen. Antibiotics. 2021;10:839.
Thombre R, Jangid K, Shukla R, Dutta NK. Alternative therapeutics against antimicrobial-resistant pathogens. Front Media SA. 2019;10:2173.
Oei JD, Zhao WW, Chu L, DeSilva MN, Ghimire A, Rawls HR, Whang K. Antimicrobial acrylic materials with in situ generated silver nanoparticles. J Biomed Mater Res B Appl Biomater. 2012;100:409–15.
Kim K-J, Sung WS, Suh BK, Moon S-K, Choi J-S, Kim JG, Lee DG. Antifungal activity and mode of action of silver nano-particles on Candida albicans. Biometals. 2009;22:235–42.
Zhang X-F, Liu Z-G, Shen W, Gurunathan S. Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches. Int J Mol Sci. 2016;17:1534.
O’Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol. 1998;30:295–304.
Kang M-G, Khan F, Jo D-M, Oh D, Tabassum N, Kim Y-M. Antibiofilm and antivirulence activities of gold and zinc oxide nanoparticles synthesized from kimchi-isolated Leuconostoc sp. Strain C2. Antibiotics. 2022;11:1524.
Khan F, Manivasagan P, Lee J-W, Pham DTN, Oh J, Kim Y-M. Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in Pseudomonas aeruginosa PAO1. Mar Drugs. 2019;17:208.
El-Deeb NM, Abo-Eleneen MA, Al-Madboly LA, Sharaf MM, Othman SS, Ibrahim OM, Mubarak MS. Biogenically synthesized polysaccharides-capped silver nanoparticles: immunomodulatory and antibacterial potentialities against resistant Pseudomonas aeruginosa. Front Bioeng Biotechnol. 2020;8:643.
Najafi M, Moghaddam MN, Yousefi E. The effect of silver nanoparticles on pyocyanin production of Pseudomonas aeruginosa isolated from clinical specimens. Avicenna J Med Biotechnol. 2021;13:98.
Price-Whelan AM. Physiology and mechanisms of pyocyanin reduction in Pseudomonas aeruginosa. Pasadena: California Institute of Technology; 2009.
Kipnis E, Sawa T, Wiener-Kronish J. Targeting mechanisms of Pseudomonas aeruginosa pathogenesis. Med Mal Infect. 2006;36:78–91.
Kumar S, Paliya BS, Singh BN. Superior inhibition of virulence and biofilm formation of Pseudomonas aeruginosa PAO1 by phyto-synthesized silver nanoparticles through anti-quorum sensing activity. Microb Pathog. 2022;170:105678.
Wei L, Wu Q, Zhang J, Guo W, Gu Q, Wu H, Wang J, Lei T, Xue L, Zhang Y. Prevalence, virulence, antimicrobial resistance, and molecular characterization of Pseudomonas aeruginosa isolates from drinking water in China. Front Microbiol. 2020;11:544653.
Nikbin V, Aslani MM, Sharafi Z, Hashemipour M, Shahcheraghi F, Ebrahimipour G. Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins. Iran J Microbiol. 2012;4:118.
Abozahra R, El-Kholy MA, Baraka K. Virulence genotyping of drug resistant Pseudomonas aeruginosa clinical isolates in Egypt using multiplex PCR. Gene Reports. 2021;22:101000.
Saeki EK, Martins HM, Camargo LCD, Anversa L, Tavares ER, Yamada-Ogatta SF, Lioni LMY, Kobayashi RKT, Nakazato G. Effect of biogenic silver nanoparticles on the quorum-sensing system of Pseudomonas aeruginosa PAO1 and PA14. Microorganisms. 2022;10:1755.
Singh BR, Singh BN, Singh A, Khan W, Naqvi AH, Singh HB. Mycofabricated biosilver nanoparticles interrupt Pseudomonas aeruginosa quorum sensing systems. Sci Rep. 2015;5:13719.
Liu L, Li J-H, Zi S-F, Liu F-R, Deng C, Ao X, Zhang P. AgNP combined with quorum sensing inhibitor increased the antibiofilm effect on Pseudomonas aeruginosa. Appl Microbiol Biotechnol. 2019;103:6195–204.
Hetta HF, Al-Kadmy IM, Khazaal SS, Abbas S, Suhail A, El-Mokhtar MA, Ellah NHA, Ahmed EA, Abd-Ellatief RB, El-Masry EA. Antibiofilm and antivirulence potential of silver nanoparticles against multidrug-resistant Acinetobacter baumannii. Sci Rep. 2021;11:10751.
Stabryla LM, Johnston KA, Millstone JE, Gilbertson LM. Emerging investigator series: it’s not all about the ion: support for particle-specific contributions to silver nanoparticle antimicrobial activity. Environ Sci Nano. 2018;5:2047–68.
Chaudhary V, Mostafavi E, Kaushik A. De-coding Ag as an efficient antimicrobial nano-system for controlling cellular/biological functions. Matter. 2022;5(7):1995–8.
Akter M, Sikder MT, Rahman MM, Ullah AA, Hossain KFB, Banik S, Hosokawa T, Saito T, Kurasaki M. A systematic review on silver nanoparticles-induced cytotoxicity: physicochemical properties and perspectives. J Adv Res. 2018;9:1–16.
Hamida RS, Ali MA, Goda DA, Khalil MI, Al-Zaban MI. Novel biogenic silver nanoparticle-induced reactive oxygen species inhibit the biofilm formation and virulence activities of methicillin-resistant Staphylococcus aureus (MRSA) strain. Front Bioeng Biotechnol. 2020;8:433.
Ihtisham M, Noori A, Yadav S, Sarraf M, Kumari P, Brestic M, Imran M, Jiang F, Yan X, Rastogi A. Silver nanoparticle’s toxicological effects and phytoremediation. Nanomaterials. 2021;11:2164.
Padmapriya S, Murugan N, Ragavendran C, Thangabalu R, Natarajan D. Phytoremediation potential of some agricultural plants on heavy metal contaminated mine waste soils, salem district, tamilnadu. Int J Phytorem. 2016;18:288–94.
Yan A, Wang Y, Tan SN, Mohd Yusof ML, Ghosh S, Chen Z. Phytoremediation: a promising approach for revegetation of heavy metal-polluted land. Front Plant Sci. 2020;11:359.
Gnanakani PE, Santhanam P, Premkumar K, Kumar KE, Dhanaraju MD. Nannochloropsis extract–mediated synthesis of biogenic silver nanoparticles, characterization and in vitro assessment of antimicrobial, antioxidant and cytotoxic activities. Asian Pac J Cancer Prev APJCP. 2019;20:2353.
Chahardoli A, Karimi N, Fattahi A. Biosynthesis, characterization, antimicrobial and cytotoxic effects of silver nanoparticles using Nigella arvensis seed extract. Iran J Pharm Res IJPR. 2017;16:1167.
Liu X, Shan K, Shao X, Shi X, He Y, Liu Z, Jacob JA, Deng L. Nanotoxic effects of silver nanoparticles on normal HEK-293 cells in comparison to cancerous HeLa cell line. Int J Nanomed. 2021;16:753–61.
Lima R, Feitosa L, Ballottin D, Marcato PD, Tasic L, Durán N. Cytotoxicity and genotoxicity of biogenic silver nanoparticles. J Phys Conf Ser. 2013;429:012020.
Arshad F, Naikoo GA, Hassan IU, Chava SR, El-Tanani M, Aljabali AA, Tambuwala MM. Bioinspired and green synthesis of silver nanoparticles for medical applications: a green perspective. Appl Biochem Biotechnol. 2024;196:3636–69.
Acknowledgements
The authors would like to thank Drug Microbiology Lab, Drug Radiation Research Department, National Center for Radiation Research and Technology (NCRRT), Egypt and Radiation Microbiology Department, National Center for Radiation Research and Technology (NCRRT), Egyptian Atomic Energy Authority (EAEA), Cairo, Egypt as well as microbiology and immunology department, faculty of pharmacy Ahram Canadian University.
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). No funding provided.
Author information
Authors and Affiliations
Contributions
All authors have contributed to conception and design or the acquisition and analysis of Data and approval of the final submitted version and drafting or critically revising the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
All experimental protocols were done following the ethical standards adopted by National Center for Radiation Research.
Consent for publication
All authors agree to participate and publish
Competing interests
The authors declare there is no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Abdel-Fatah, S.S., Mohammad, N.H., Elshimy, R. et al. Impeding microbial biofilm formation and Pseudomonas aeruginosa virulence genes using biologically synthesized silver Carthamus nanoparticles. Microb Cell Fact 23, 240 (2024). https://doi.org/10.1186/s12934-024-02508-9
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12934-024-02508-9